MPD: Phenotype measures mapped to MA:0000522, abdomen organ

Phenotype measures associated with ontology term
MA:0000522 'abdomen organ'

All measures in this list are mapped to the ontology descendants of MA:0000522. None are mapped to MA:0000522 directly.

MA:0000116 adrenal gland
MA:0000120 pancreas
MA:0000127 pancreatic islet
MA:0000141 spleen
MA:0000328 intestine
MA:0000334 cecum
MA:0000335 colon
MA:0000356 gall bladder
MA:0000358 liver
MA:0000368 kidney

Sort/ Pick	Data set	Procedure / Protocol	Treatment	Phenotype Measure / Variable (click to view)	Panel	No. of Strains	Sex	Age	Sample Size (Avg)	Year

Ankra-Badu1:8	Ankra-Badu1	organ weights	(none)	liver weight [mg] LIVER 21208	QTL population		both	10wks	N=502	2009

Ankra-Badu1:9	Ankra-Badu1	organ weights	(none)	right kidney weight [mg] KIDNEY 21209	QTL population		both	10wks	N=502	2009

Ankra-Badu1:10	Ankra-Badu1	organ weights	(none)	spleen weight [mg] SPLEEN 21210	QTL population		both	10wks	N=502	2009

Attie2:99	Attie2	microscopy	high-fat high-sucrose diet	number of islets harvested per mouse after diet [n] islets 110716	DO population		both	19-26wks	N=242	2018

Attie2:100	Attie2	hormone quantification	high-fat high-sucrose diet	amount of insulin per islet after diet [ng/mL] INS_per_islet 110717	DO population		both	19-26wks	N=241	2018

Attie2:101	Attie2	hormone quantification	high-fat high-sucrose diet	whole pancreas insulin content after diet (insulin content per islet times number of islets) [ng/mL] INS_per_pancreas 110718	DO population		both	19-26wks	N=241	2018

Attie2:102	Attie2	hormone quantification	high-fat high-sucrose diet	ex vivo insulin secretion after diet in response to glucose [ng/mL] INS_GLU 110719 3.3 mM 8.3 mM 16.7 mM	DO population		both	19-26wks	N=242	2018

Attie2:105	Attie2	hormone quantification	high-fat high-sucrose diet	ex vivo insulin secretion after diet in response to 3.3 mM glucose plus 40 mM KCl [ng/mL] INS_GLU3p3_KCl 110722	DO population		both	19-26wks	N=240	2018

Attie2:106	Attie2	hormone quantification	high-fat high-sucrose diet	ex vivo insulin secretion after diet in response to 8.3 mM glucose plus 100 nM GLP-1 [ng/mL] INS_GLU8p3_GLP1 110723	DO population		both	19-26wks	N=240	2018

Attie2:107	Attie2	hormone quantification	high-fat high-sucrose diet	ex vivo insulin secretion after diet in response to 8.3 mM glucose plus a mix of amino acids (Ala, Glu, Leu) [ng/mL] INS_GLU8p3_AA 110724	DO population		both	19-26wks	N=240	2018

Attie2:108	Attie2	hormone quantification	high-fat high-sucrose diet	ex vivo insulin secretion after diet in response to 16.7 mM glucose plus 0.5 mM palmitic acid [ng/mL] INS_GLU16p7_PA 110725	DO population		both	19-26wks	N=240	2018

Attie2:109	Attie2	hormone quantification	high-fat high-sucrose diet	ex vivo insulin secretion after diet in response to 8.3 mM glucose, expressed as fold-change over that observed with 3.3 mM glucose [ratio] INS_GLU8p3_fc_G3p3 110726	DO population		both	19-26wks	N=240	2018

Attie2:110	Attie2	hormone quantification	high-fat high-sucrose diet	ex vivo insulin secretion after diet in response to 16.7 mM glucose, expressed as fold-change over that observed with 3.3.mM glucose [ratio] INS_GLU16p7_fc_G3p3 110727	DO population		both	19-26wks	N=240	2018

Attie2:111	Attie2	hormone quantification	high-fat high-sucrose diet	ex vivo insulin secretion after diet in response to 3.3 mM glucose plus 40 mM KCl, expressed as fold-change over that observed with 3.3 mM glucose [ratio] INS_GLU3p3__KCl_fc_G3p3 110728	DO population		both	19-26wks	N=240	2018

Attie2:112	Attie2	hormone quantification	high-fat high-sucrose diet	ex vivo insulin secretion after diet in response to 8.3 mM glucose plus 100 nM GLP-1, expressed as fold-change over that observed with 3.3 mM glucose [ratio] INS_GLU8p3_GLP1_fc_G3p3 110729	DO population		both	19-26wks	N=240	2018

Attie2:113	Attie2	hormone quantification	high-fat high-sucrose diet	ex vivo insulin secretion after diet in response to 8.3 mM glucose plus a mix of amino acids (Ala, Glu, Leu), expressed as fold-change over that observed with 3.3 mM glucose [ratio] INS_GLU8p3_AA_fc_G3p3 110730	DO population		both	19-26wks	N=240	2018

Attie2:114	Attie2	hormone quantification	high-fat high-sucrose diet	ex vivo insulin secretion after diet in response to 16.7 mM glucose plus palmitic acid, expressed as fold-change over that observed with 3.3 mM glucose [ratio] INS_GLU16p7_PA_fc_G3p3 110731	DO population		both	19-26wks	N=240	2018

Attie2:115	Attie2	hormone quantification	high-fat high-sucrose diet	ex vivo insulin secretion after diet in response to 3.3 mM glucose plus 40 mM KCl, expressed as fold-change over that observed with 8.3 mM glucose [ratio] INS_GLU8p3_GLP1_fc_G8p3 110732	DO population		both	19-26wks	N=240	2018

Attie2:116	Attie2	hormone quantification	high-fat high-sucrose diet	ex vivo insulin secretion after diet in response to 8.3 mM glucose plus a mix of amino acids (Ala, Glu, Leu), expressed as fold-change over that observed with 8.3 mM glucose [ratio] INS_GLU8p3_AA_fc_G8p3 110733	DO population		both	19-26wks	N=240	2018

Attie2:117	Attie2	hormone quantification	high-fat high-sucrose diet	ex vivo insulin secretion after diet in response to 16.7 mM glucose plus 0.5 mM palmitic acid, expressed as fold-change over that observed with 16.7 mM glucose [ratio] INS_GLU16p7_PA_fc_G16p7 110734	DO population		both	19-26wks	N=240	2018

Attie2:118	Attie2	hormone quantification	high-fat high-sucrose diet	ex vivo insulin secretion after diet in response to glucose, expressed as a percentage of total insulin per mouse [%] INS_pct_GLU 110735 3.3 mM 8.3 mM 16.7 mM	DO population		both	19-26wks	N=241	2018

Attie2:121	Attie2	hormone quantification	high-fat high-sucrose diet	ex vivo insulin secretion after diet in response to 3.3 mM glucose plus 40 mM KCl, expressed as a percentage of total insulin per mouse [%] INS_GLU3p3_KCl_pct 110738	DO population		both	19-26wks	N=239	2018

Attie2:122	Attie2	hormone quantification	high-fat high-sucrose diet	ex vivo insulin secretion after diet in response to 8.3 mM glucose plus 100 nM GLP-1, expressed as a percentage of total insulin per mouse [%] INS_GLU8p3_GLP1_pct 110739	DO population		both	19-26wks	N=239	2018

Attie2:123	Attie2	hormone quantification	high-fat high-sucrose diet	ex vivo insulin secretion after diet in response to 8.3 mM glucose plus a mix of amino acids (Ala, Glu, Leu), expressed as a percentage of total insulin per mouse [%] INS_GLU8p3_AA_pct 110740	DO population		both	19-26wks	N=239	2018

Attie2:124	Attie2	hormone quantification	high-fat high-sucrose diet	ex vivo insulin secretion after diet in response to 16.7 mM glucose plus 0.5 mM palmitic acid, expressed as a percentage of total insulin per mouse [%] INS_GLU16p7_PA_pct 110741	DO population		both	19-26wks	N=239	2018

Attie2:125	Attie2	hormone quantification	high-fat high-sucrose diet	ex vivo insulin secretion after diet in response to glucose (geometric mean) [ng/mL] INS_gm_GLU 110742 3.3 mM 8.3 mM 16.7 mM	DO population		both	19-26wks	N=242	2018

Attie2:128	Attie2	hormone quantification	high-fat high-sucrose diet	ex vivo insulin secretion after diet in response to 3.3 mM glucose plus 40 mM KCl (geometric mean) [ng/mL] INS_gm_GLU3p3_KCl 110745	DO population		both	19-26wks	N=240	2018

Attie2:129	Attie2	hormone quantification	high-fat high-sucrose diet	ex vivo insulin secretion after diet in response to 8.3 mM glucose plus 100 nM GLP-1 (geometric mean) [ng/mL] INS_gm_GLU8p3_GLP1 110746	DO population		both	19-26wks	N=240	2018

Attie2:130	Attie2	hormone quantification	high-fat high-sucrose diet	ex vivo insulin secretion after diet in response to 8.3 mM glucose plus a mix of amino acids (Ala, Glu, Leu) (geometric mean) [ng/mL] INS_gm_GLU8p3_AA 110747	DO population		both	19-26wks	N=240	2018

Attie2:131	Attie2	hormone quantification	high-fat high-sucrose diet	ex vivo insulin secretion after diet in response to 16.7 mM glucose plus 0.5 mM palmitic acid (geometric mean) [ng/mL] INS_gm_GLU16p7_PA 110748	DO population		both	19-26wks	N=240	2018

Attie2:132	Attie2	hormone quantification	high-fat high-sucrose diet	amount of glucagon per islet after diet [ng/mL] GCG_per_islet 110749	DO population		both	19-26wks	N=241	2018

Attie2:133	Attie2	hormone quantification	high-fat high-sucrose diet	ex vivo glucagon secretion after diet in response to 3.3 mM glucose plus 40 mM KCl [ng/mL] GCG_GLU3p3_KCl 110750	DO population		both	19-26wks	N=182	2018

Attie2:134	Attie2	hormone quantification	high-fat high-sucrose diet	ex vivo glucagon secretion after diet in response to 3.3 mM glucose plus 40 mM KCl, expressed as a percentage of total glucagon per mouse [%] GCG_GLU3p3_KCl_pct 110751	DO population		both	19-26wks	N=182	2018

Attie2:137	Attie2	organ weights	high-fat high-sucrose diet	liver left lobe weight after diet [g] liver_wt_L 110754	DO population		both	19-26wks	N=194	2018

Attie2:138	Attie2	organ weights	high-fat high-sucrose diet	liver weight minus left lobe after diet [g] liver_wt_remain 110755	DO population		both	19-26wks	N=194	2018

Attie2:139	Attie2	organ weights	high-fat high-sucrose diet	liver weight total after diet [g] liver_wt_tot 110756	DO population		both	19-26wks	N=194	2018

Auwerx1:225	Auwerx1	organ weights	high-fat diet	kidney weight (both) [g] kidney_wt 111404 CD HFD	BXD w/par	57	m	29wks	N=4	2016

Auwerx1:227	Auwerx1	organ weights	high-fat diet	liver weight [g] liver_wt 111406 CD HFD	BXD w/par	57	m	29wks	N=4	2016

Auwerx2:123	Auwerx2	organ weights	(none)	cecum weight [g] cecum_wt 114651 CD HFD	inbred w/CC8	9	both	21wks	N=4	2021

Auwerx2:131	Auwerx2	organ weights	(none)	kidney weight (both) [g] kidney_wt 114659 CD HFD	inbred w/CC8	9	both	21wks	N=4	2021

Auwerx2:133	Auwerx2	organ weights	(none)	liver weight [g] liver_wt 114661 CD HFD	inbred w/CC8	9	both	21wks	N=4	2021

Auwerx2:135	Auwerx2	organ weights	(none)	spleen weight [g] spleen_wt 114663 CD HFD	inbred w/CC8	9	both	21wks	N=4	2021

Auwerx2:141	Auwerx2	organ dimensions	(none)	intestine length [cm] intestine_length 114669 CD HFD	inbred w/CC8	9	both	21wks	N=4	2021

Benoist1:1	Benoist1	immune cell quantification	(none)	percentage of thymic CD4 Treg cells that are CD25^hi [%] Treg_thy_CD25 25801	inbred	33	m	5-6wks	N=3	2007

Benoist1:2	Benoist1	immune cell quantification	(none)	percentage of thymic CD4 Treg cells that are Foxp3+ [%] Treg_thy_Foxp3 25802	inbred	10	m	5-6wks	N=3	2007

Benoist1:3	Benoist1	immune cell quantification	(none)	percentage of splenic CD4 Treg cells that are CD25^hi [%] Treg_spl_CD25 25803	inbred	31	m	5-6wks	N=3	2007

Benoist1:4	Benoist1	immune cell quantification	(none)	percentage of splenic CD4 Treg cells that are Foxp3+ [%] Treg_spl_Foxp3 25804	inbred	10	m	5-6wks	N=3	2007

Bopp1:5	Bopp1	health assessment	Plasmodium berghei	percentage of parasites in spleen relative to all organs tested [%] luciferase_spleen 36405	inbred	28	both	8-12wks	N=2	2010

Bopp1:7	Bopp1	health assessment	Plasmodium berghei	percentage of parasites in liver relative to all organs tested [%] luciferase_liver 36407	inbred	28	both	8-12wks	N=2	2010

Brockmann1:9	Brockmann1	organ weights	(none)	weight of liver [mg] Liver 21309	QTL population		both	6wks	N=138	2009

Brockmann1:10	Brockmann1	organ weights	(none)	weight of kidney [mg] Kidney 21310	QTL population		both	6wks	N=138	2009

Brockmann1:11	Brockmann1	organ weights	(none)	weight of spleen [mg] Spleen 21311	QTL population		both	6wks	N=138	2009

Brockmann1:26	Brockmann1	organ weights	(none)	weight of liver [mg] liver 21506	QTL population		both	6wks	N=201	2009

Brockmann1:27	Brockmann1	organ weights	(none)	weight of kidney [mg] kidney 21507	QTL population		both	6wks	N=201	2009

Brockmann1:28	Brockmann1	organ weights	(none)	weight of spleen [mg] spleen 21508	QTL population		both	6wks	N=201	2009

Broman1:1	Broman1	organ dimensions	(none)	gut length of mouse [cm] gutlength 18301	QTL population		both		N=534	2006

Chen1:3	Chen1	immune cell quantification	(none)	percentage of total TCRβ+ cells that are invariant NK T cells, spleen [%] pct_iNKT_T_spleen 52303	inbred	38	m	8-10wks	N=4	2011

Chen1:4	Chen1	immune cell quantification	(none)	percentage of invariant NK T cells that express CD4, spleen [%] pct_iNKT_CD4_spleen 52304	inbred	35	m	8-10wks	N=4	2011

Chen1:5	Chen1	immune cell quantification	(none)	peripheral blood to spleen ratio of invariant NK T cells [ratio] iNKT_pb_spl_ratio 52305	inbred	38	m	8-10wks	N=4	2011

Chesler2:64	Chesler2	organ weights	(none)	kidney (left) weight [g] kidneyL_wt 43496	CC diallel w/par	46	both	7-15wks	N=3	2011

Chesler3:93	Chesler3	organ dimensions	(none)	kidney length [cm] kidney_length 43593 left right	CC pre w/par	124	both	7-15wks	N=1	2011

Chesler3:95	Chesler3	organ dimensions	(none)	kidney volume [cm³] kidney_vol 43595	CC pre w/par	77	both	7-15wks	N=1	2011

Chesler3:96	Chesler3	organ weights	(none)	kidney weight [g] kidney_wt 43596 left right both	CC pre w/par	351	both	7-15wks	N=2	2011

Chesler3:99	Chesler3	organ weights	(none)	spleen weight [g] spleen_wt 43599	CC pre w/par	263	both	7-15wks	N=2	2011

Cheverud1:17	Cheverud1	organ weights	high-fat diet	kidney weight (both) as percentage of body weight [%] kidneywt_adj 17820 control diet high-fat diet	LGXSM w/par	17	both	20-30wks	N=8	2004

Cheverud1:21	Cheverud1	organ weights	high-fat diet	spleen weight as percentage of body weight [%] spleenwt_adj 17822 control diet high-fat diet	LGXSM w/par	17	both	20-30wks	N=8	2004

Cheverud1:23	Cheverud1	organ weights	high-fat diet	liver weight as percentage of body weight [%] liverwt_adj 17823 control diet high-fat diet	LGXSM w/par	17	both	20-30wks	N=8	2004

Cowell1:3	Cowell1	in vitro assay	Staphylococcus aureus	log₁₀ bacterial colony count from kidney 24h post-infection (CFU/g) [log(n/g)] kidney_CFU 49003	inbred	13	f	8wks	N=6	2012

Deschepper1:17	Deschepper1	organ weights	(none)	adrenal weight [mg] adrenal 10417 right left both	inbred	13	both	10wks	N=10	2004

Deschepper1:18	Deschepper1	organ weights	(none)	adrenal weight, normalized to body weight [mg] adrenal_adj 10418 right left both	inbred	13	both	10wks	N=10	2004

Deschepper1:23	Deschepper1	organ weights	(none)	kidney weight [mg] kidney 10423 right left both	inbred	13	both	10wks	N=10	2004

Deschepper1:24	Deschepper1	organ weights	(none)	kidney weight, normalized to body weight [mg] kidney_adj 10424 right left both	inbred	13	both	10wks	N=10	2004

DiCurzio1:2	DiCurzio1	organ weights	(none)	adrenal weights [mg] adr_wt 36602 left right	BXD w/par	66	both	7-10wks*	N=4	2010

DiCurzio1:4	DiCurzio1	organ weights	(none)	mean weight of both adrenals [mg] adr_wt_ave 36604	BXD w/par	66	both	7-10wks*	N=4	2010

DiCurzio1:5	DiCurzio1	organ weights	(none)	total weight of adrenals adjusted to body weight (x10^-3) [mg] adr_adj_bw 36605	BXD w/par	66	both	7-10wks*	N=4	2010

DiCurzio1:6	DiCurzio1	histopathology	(none)	adrenal total width, diameter [µm] adr_width 36606	BXD w/par	66	both	7-10wks*	N=3	2010

DiCurzio1:7	DiCurzio1	histopathology	(none)	adrenal medulla width [µm] adr_medul_width 36607	BXD w/par	66	both	7-10wks*	N=3	2010

DiCurzio1:8	DiCurzio1	histopathology	(none)	adrenal cortex zona glomerulosa thickness [µm] adr_glome_width 36608	BXD w/par	66	both	7-10wks*	N=3	2010

DiCurzio1:9	DiCurzio1	histopathology	(none)	adrenal cortex zona intermedia thickness [µm] adr_inter_width 36609	BXD w/par	66	both	7-10wks*	N=3	2010

DiCurzio1:10	DiCurzio1	histopathology	(none)	adrenal cortex zona fasciculata thickness [µm] adr_fasci_width 36610	BXD w/par	66	both	7-10wks*	N=3	2010

DiCurzio1:11	DiCurzio1	histopathology	(none)	adrenal cortex zona reticularis thickness [µm] adr_retic_width 36611	BXD w/par	66	both	7-10wks*	N=3	2010

DiCurzio1:12	DiCurzio1	histopathology	(none)	adrenal cortex X-zone thickness [µm] adr_Xzone_width 36612	BXD w/par	66	both	7-10wks*	N=3	2010

DiCurzio1:14	DiCurzio1	histopathology	(none)	adrenal glands, presence of X-zone (0=no; 1=yes) [score] Xzone_presence 36614	BXD w/par	66	both	7-10wks*	N=4	2010

DiCurzio1:15	DiCurzio1	histopathology	(none)	adrenal glands, presence of lipoid structures in females (0=none; 1=outside X-zone; 2=within X-zone) [score] lipoid_presence 36615	BXD w/par	66	f	7-10wks*	N=4	2010

Farmer1:1	Farmer1	histopathology	(none)	severity of lesions in cecum [score] CecumSeverity 11301	QTL population		both	6wks	N=206	2001

Farmer1:2	Farmer1	histopathology	(none)	hyperplasia of cecum [score] CecumHyperplasia 11302	QTL population		both	6wks	N=206	2001

Farmer1:3	Farmer1	histopathology	(none)	ulceration in cecum [score] CecumUlceration 11303	QTL population		both	6wks	N=206	2001

Farmer1:4	Farmer1	histopathology	(none)	percentage of cecum damaged area [%] CecumDA 11304	QTL population		both	6wks	N=206	2001

Farmer1:5	Farmer1	histopathology	(none)	sum of cecum severity, hyperplasia, ulceration and damaged area scores [score] CecumTotalScore 11305	QTL population		both	6wks	N=206	2001

Farmer1:6	Farmer1	histopathology	(none)	percentage of proximal colon damaged area [%] ProxDA 11306	QTL population		both	6wks	N=206	2001

Farmer1:7	Farmer1	histopathology	(none)	severity of lesions in proximal colon [score] ProxSeverity 11307	QTL population		both	6wks	N=206	2001

Farmer1:8	Farmer1	histopathology	(none)	hyperplasia of proximal colon [score] ProxHyperplasia 11308	QTL population		both	6wks	N=206	2001

Farmer1:9	Farmer1	histopathology	(none)	ulceration in proximal colon [score] ProxUlceration 11309	QTL population		both	6wks	N=206	2001

Farmer1:10	Farmer1	histopathology	(none)	percentage of damaged area in mid colon [%] MidDA 11310	QTL population		both	6wks	N=206	2001

Farmer1:11	Farmer1	histopathology	(none)	severity of lesions in mid colon [score] MidSeverity 11311	QTL population		both	6wks	N=206	2001

Farmer1:12	Farmer1	histopathology	(none)	hyperplasia of mid colon [score] MidHyperplasia 11312	QTL population		both	6wks	N=206	2001

Farmer1:13	Farmer1	histopathology	(none)	ulcers and crypts frequency score [score] MidUlceration 11313	QTL population		both	6wks	N=206	2001

Farmer1:14	Farmer1	histopathology	(none)	percentage of damaged area in distal colon [%] DistalDA 11314	QTL population		both	6wks	N=206	2001

Farmer1:15	Farmer1	histopathology	(none)	severity of lesions in distal colon [score] DistalSeverity 11315	QTL population		both	6wks	N=206	2001

Farmer1:16	Farmer1	histopathology	(none)	hyperplasia of distal colon [score] DistalHyperplasia 11316	QTL population		both	6wks	N=206	2001

Farmer1:17	Farmer1	histopathology	(none)	ulceration in distal colon [score] DistalUlceration 11317	QTL population		both	6wks	N=206	2001

Farmer1:18	Farmer1	histopathology	(none)	proximal colon score [score] ProximalColon 11318	QTL population		both	6wks	N=206	2001

Farmer1:19	Farmer1	histopathology	(none)	middle colon score [score] MiddleColon 11319	QTL population		both	6wks	N=206	2001

Farmer1:20	Farmer1	histopathology	(none)	distal colon score [score] DistalColon 11320	QTL population		both	6wks	N=206	2001

Farmer1:21	Farmer1	histopathology	(none)	total score [score] ColonTotalScore 11321	QTL population		both	6wks	N=206	2001

Farmer1:23	Farmer1	organ weights	(none)	spleen weight [g] SpleenWeight 11323	QTL population		both	6wks	N=206	2001

Farmer1:24	Farmer1	organ weights	(none)	spleen/body weight ratio [%] SplBW 11324	QTL population		both	6wks	N=206	2001

Feng1:3	Feng1	organ weights	(none)	left kidney weight [g] LKW 21603	QTL population		m	8wks	N=336	2009

Feng1:4	Feng1	organ weights	(none)	right kidney weight [g] RKW 21604	QTL population		m	8wks	N=336	2009

GMC21:4	GMC21	organ weights	(none)	liver weight [g] liver_wt 57004	inbred w/CC8	8	both	21wks	N=11	2018

GMC21:5	GMC21	organ weights	(none)	spleen weight [g] spleen_wt 57005	inbred w/CC8	8	both	21wks	N=11	2018

Graham1:33	Graham1	immune cell quantification	West Nile virus	percentage of CD3+ T cells that are CD4+ in spleen, post infection [%] CD4_spleen 63333 day 7 day 12 day 21 day 28	CC RIX	2	m	8-10wks	N=3	2015

Graham1:41	Graham1	immune cell quantification	West Nile virus	percentage of CD4+ T cells that are Foxp3+ in the spleen, post infection [%] Treg_spleen 63341 day 7 day 12 day 21 day 28	CC RIX	2	m	8-10wks	N=3	2015

Graham1:49	Graham1	immune cell quantification	West Nile virus	percentage of CD3+ T cells that are CD8+ in spleen, post infection [%] CD8_spleen 63349 day 7 day 12 day 21 day 28	CC RIX	2	m	8-10wks	N=3	2015

Graham1:57	Graham1	immune cell quantification	West Nile virus	percentage of CD3+ T cells that are NS4b+ in spleen, post infection [%] NS4b_spleen 63357 day 7 day 12 day 21 day 28	CC RIX	2	m	8-10wks	N=3	2015

Graham1:68	Graham1	RNA expression profiling	West Nile virus	virus in kidney, fold change compared to matched control, post infection WNV_kidney 63368 day 2 day 4 day 7 day 12	CC RIX	5	m	8-10wks	N=1	2015

Graham1:72	Graham1	RNA expression profiling	West Nile virus	virus in spleen, fold change compared to matched control, post infection WNV_spleen 63372 day 2 day 4 day 7 day 12	CC RIX	5	m	8-10wks	N=1	2015

Graham1:79	Graham1	RNA expression profiling	West Nile virus	Ifnb1 gene expression in kidney, fold change compared to matched control, post infection Ifnb1_kidney 63379 day 2 day 4 day 7 day 12	CC RIX	5	m	8-10wks	N=1	2015

Graham1:83	Graham1	RNA expression profiling	West Nile virus	Ifnb1 gene expression in spleen, fold change compared to matched control, post infection Ifnb1_spleen 63383 day 2 day 4 day 7 day 12	CC RIX	5	m	8-10wks	N=1	2015

Graham1:90	Graham1	RNA expression profiling	West Nile virus	Ifit1 gene expression in kidney, fold change compared to matched control, post infection Ifit1_kidney 63390 day 2 day 4 day 7 day 12	CC RIX	5	m	8-10wks	N=1	2015

Graham1:94	Graham1	RNA expression profiling	West Nile virus	Ifit1 gene expression in spleen, fold change compared to matched control, post infection Ifit1_spleen 63394 day 2 day 4 day 7 day 12	CC RIX	5	m	8-10wks	N=1	2015

Graham3:9	Graham3	immune cell quantification	(none)	percentage of splenic lymphocytes that are CD4+ T cells [%] CD4_pos_tot 113800	CC RIX	102	m	8-10wks	N=4	2021

Graham3:10	Graham3	immune cell quantification	(none)	percentage of splenic CD4+ T cells that are Foxp3+ (Treg) [%] Tregs 113801	CC RIX	102	m	8-10wks	N=4	2021

Graham3:11	Graham3	immune cell quantification	(none)	percentage of splenic Treg cells that are CD29+ [%] Treg_CD29_pos 113802	CC RIX	102	m	8-10wks	N=4	2021

Graham3:12	Graham3	immune cell quantification	(none)	percentage of splenic Treg cells that are CD44hi [%] Treg_CD44_hi 113803	CC RIX	102	m	8-10wks	N=4	2021

Graham3:13	Graham3	immune cell quantification	(none)	percentage of splenic Treg cells that are CD73+ [%] Treg_CD73_pos 113804	CC RIX	102	m	8-10wks	N=4	2021

Graham3:14	Graham3	immune cell quantification	(none)	percentage of splenic Treg cells that are CTLA-4+ [%] Treg_CTLA4_pos 113805	CC RIX	102	m	8-10wks	N=4	2021

Graham3:15	Graham3	immune cell quantification	(none)	percentage of splenic Treg cells that are CXCR3+ [%] Treg_CXCR3_pos 113806	CC RIX	102	m	8-10wks	N=4	2021

Graham3:16	Graham3	immune cell quantification	(none)	percentage of splenic Treg cells that are ICOS+ (inducible costimulator) [%] Treg_ICOS_pos 113807	CC RIX	102	m	8-10wks	N=4	2021

Graham3:21	Graham3	immune cell quantification	(none)	percentage of splenic lymphocytes that are CD3+ T cells (memory precursor panel) [%] mp_CD3_pos 113812	CC RIX	92	m	8-10wks	N=4	2021

Graham3:22	Graham3	immune cell quantification	(none)	percentage of splenic CD3+ T cells that are CD8+ (memory precursor panel) [%] mp_CD3_pos_CD8_pos 113813	CC RIX	92	m	8-10wks	N=4	2021

Graham3:23	Graham3	immune cell quantification	(none)	percentage of splenic CD8+ T cells that are CD44+ (memory precursor panel) [%] mp_CD8_pos_CD44_pos 113814	CC RIX	91	m	8-10wks	N=4	2021

Graham3:24	Graham3	immune cell quantification	(none)	percentage of splenic CD8+ T cells that are CD62L- (memory precursor panel) [%] mp_CD8_pos_CD62L_neg 113815	CC RIX	76	m	8-10wks	N=3	2021

Graham3:25	Graham3	immune cell quantification	(none)	percentage of splenic CD8+ T cells that are Ki67+ (memory precursor panel) [%] mp_CD8_pos_Ki67_pos 113816	CC RIX	92	m	8-10wks	N=4	2021

Graham3:26	Graham3	immune cell quantification	(none)	percentage of splenic CD3+ T cells that are CD4+ (memory precursor panel) [%] mp_CD3_pos_CD4_pos 113817	CC RIX	92	m	8-10wks	N=4	2021

Graham3:27	Graham3	immune cell quantification	(none)	percentage of splenic CD4+ T cells that are CD44+ (memory precursor panel) [%] mp_CD4_pos_CD44_pos 113818	CC RIX	91	m	8-10wks	N=4	2021

Graham3:28	Graham3	immune cell quantification	(none)	percentage of splenic CD4+ T cells that are CD62L- (memory precursor panel) [%] mp_CD4_pos_CD62L_neg 113819	CC RIX	73	m	8-10wks	N=3	2021

Graham3:29	Graham3	immune cell quantification	(none)	percentage of splenic CD4+ T cells that are Ki67+ (memory precursor panel) [%] mp_CD4_pos_Ki67_pos 113820	CC RIX	92	m	8-10wks	N=4	2021

Graham3:34	Graham3	immune cell quantification	(none)	percentage of splenic lymphocytes that are CD3+ T cells (memory panel) [%] mem_CD3_pos 113825	CC RIX	68	m	8-10wks	N=3	2021

Graham3:35	Graham3	immune cell quantification	(none)	percentage of splenic CD3+ T cells that are CD8+ (memory panel) [%] mem_CD3_pos_CD8_pos 113826	CC RIX	68	m	8-10wks	N=3	2021

Graham3:36	Graham3	immune cell quantification	(none)	percentage of splenic CD8+ T cells that are CD44+ (memory panel) [%] mem_CD8_pos_CD44_pos 113827	CC RIX	73	m	8-10wks	N=3	2021

Graham3:37	Graham3	immune cell quantification	(none)	percentage of splenic CD8+ T cells that are CD62L- (memory panel) [%] mem_CD8_pos_CD62L_neg 113828	CC RIX	68	m	8-10wks	N=3	2021

Graham3:38	Graham3	immune cell quantification	(none)	percentage of splenic CD8+ T cells that are Ki67+ (memory panel) [%] mem_CD8_pos_Ki67_pos 113829	CC RIX	73	m	8-10wks	N=3	2021

Graham3:39	Graham3	immune cell quantification	(none)	percentage of splenic CD3+ T cells that are CD4+ (memory panel) [%] mem_CD3_pos_CD4_pos 113830	CC RIX	68	m	8-10wks	N=3	2021

Graham3:40	Graham3	immune cell quantification	(none)	percentage of splenic CD4+ T cells that are CD44+ (memory panel) [%] mem_CD4_pos_CD44_pos 113831	CC RIX	73	m	8-10wks	N=3	2021

Graham3:41	Graham3	immune cell quantification	(none)	percentage of splenic CD4+ T cells that are CD62L- (memory panel) [%] mem_CD4_pos_CD62L_neg 113832	CC RIX	68	m	8-10wks	N=3	2021

Graham3:42	Graham3	immune cell quantification	(none)	percentage of splenic CD4+ T cells that are Ki67+ (memory panel) [%] mem_CD4_pos_Ki67_pos 113833	CC RIX	73	m	8-10wks	N=3	2021

Graham3:47	Graham3	immune cell quantification	(none)	percentage of splenic lymphocytes that are CD3+ T cells following stimulation with anti-CD3 and anti CD28 [%] ics_CD3_pos 113838	CC RIX	102	m	8-10wks	N=4	2021

Graham3:48	Graham3	immune cell quantification	(none)	percentage of splenic CD3+ T cells that are CD8+ following stimulation with anti-CD3 and anti-CD28 [%] ics_CD3_pos_CD8_pos 113839	CC RIX	102	m	8-10wks	N=4	2021

Graham3:49	Graham3	immune cell quantification	(none)	percentage of splenic CD8+ T cells that are IL-17+ by intracellular cytokine staining following stimulation with anti-CD3 and anti-CD28 [%] ics_CD8_pos_IL17_pos 113840	CC RIX	102	m	8-10wks	N=4	2021

Graham3:50	Graham3	immune cell quantification	(none)	percentage of splenic CD8+ T cells that are IFNg+ by intracellular cytokine staining following stimulation with anti-CD3 and anti-CD28 [%] ics_CD8_pos_IGNg_pos 113841	CC RIX	102	m	8-10wks	N=4	2021

Graham3:51	Graham3	immune cell quantification	(none)	percentage of splenic CD3+ T cells that are CD4+ following stimulation with anti-CD3 and anti-CD28 [%] ics_CD3_pos_CD4_pos 113842	CC RIX	102	m	8-10wks	N=4	2021

Graham3:52	Graham3	immune cell quantification	(none)	percentage of splenic CD4+ T cells that are IL-17+ by intracellular cytokine staining following stimulation with anti-CD3 and anti-CD28 [%] ics_CD4_pos_IL17_pos 113843	CC RIX	102	m	8-10wks	N=4	2021

Graham3:53	Graham3	immune cell quantification	(none)	percentage of splenic CD4+ T cells that are IFNg+ by intracellular cytokine staining following stimulation with anti-CD3 and anti-CD28 [%] ics_CD4_pos_IFNg_pos 113844	CC RIX	102	m	8-10wks	N=4	2021

Graham3:54	Graham3	immune cell quantification	(none)	percentage of splenic CD4+ T cells that are Tbet+ (transcription factor) by intracellular staining following stimulation with anti-CD3 and anti-CD28 [%] ics_CD4_pos_Tbet_pos 113845	CC RIX	92	m	8-10wks	N=4	2021

Gros1:1	Gros1	in vitro assay	Candida albicans	kidney fungal load 48h post-infection, colony-forming units (log₁₀ CFU per kidney) [log(n)] fungal_load 38501	inbred	23	f	8-12wks	N=9	2011

Gros1:2	Gros1	in vitro assay	Candida albicans	susceptibility to C. albicans based on fungal load (0=susceptible; 1=resistant) [designation] susceptibility 38502	inbred	23	f	8-12wks	N=9	2011

Guay-Woodford1:2	Guay-Woodford1	organ dimensions	(none)	length of kidney [mm] kidney_length 10702	QTL population		f	2wks	N=144	2000

Guay-Woodford1:3	Guay-Woodford1	organ dimensions	(none)	kidney length normalized to body length [ratio] K_CR 10703	QTL population		f	2wks	N=144	2000

Guay-Woodford1:4	Guay-Woodford1	histopathology	(none)	renal cystic disease severity [score] severity 10704	QTL population		f	2wks	N=144	2000

Gupta1:2	Gupta1	organ weights	(none)	kidney weight [g] kidney 39102 left right both	inbred	7	both	postnatal d1	N=9	2011

Gupta1:5	Gupta1	organ weights	(none)	percent kidney weight to body weight [%] pct_kidney 39105 left right both	inbred	7	both	postnatal d1	N=9	2011

Gupta1:8	Gupta1	organ dimensions	(none)	kidney planar surface area [mm²] area_kidney 39109 left right	inbred	8	both	postnatal d1	N=9	2011

Gupta1:10	Gupta1	organ dimensions	(none)	normalized kidney planar surface area [mm²/g] adj_area_kidney 39112 left right	inbred	7	both	postnatal d1	N=9	2011

Gupta2:2	Gupta2	organ weights	(none)	kidney weight [g] kidney 39202 left right both	BXH	10	both	postnatal d1	N=14	2011

Gupta2:5	Gupta2	organ weights	(none)	percent kidney weight to body weight [%] pct_kidney 39205 left right both	BXH	10	both	postnatal d1	N=14	2011

Gupta2:8	Gupta2	organ dimensions	(none)	kidney planar surface area [mm²] area_kidney 39209 left right	BXH	10	both	postnatal d1	N=14	2011

Gupta2:10	Gupta2	organ dimensions	(none)	normalized kidney planar surface area [mm²/g] adj_area_kidney 39212 left right	BXH	10	both	postnatal d1	N=14	2011

Harrill1:5	Harrill1	organ weights	isoniazid	liver weight [g] liver 39505 control isoniazid	inbred	34	f	8-10wks	N=4	2011

Harrill1:7	Harrill1	organ weights	isoniazid	liver weight as percentage of body weight [%] pct_liver 39507 control isoniazid	inbred	34	f	8-10wks	N=4	2011

Harrill1:11	Harrill1	organ weights	isoniazid	spleen weight [g] spleen 39511 control isoniazid	inbred	34	f	8-10wks	N=4	2011

Harrill1:13	Harrill1	organ weights	isoniazid	spleen weight as percentage of body weight [%] pct_spleen 39513 control isoniazid	inbred	34	f	8-10wks	N=4	2011

Harrill1:26	Harrill1	lipid profile	isoniazid	hepatic cholesterol (CHOL) [mg/dL] liver_CHOL 39526 control isoniazid	inbred	34	f	8-10wks	N=4	2011

Harrill1:31	Harrill1	lipid profile	isoniazid	hepatic triglycerides (TG) [mg/dL] liver_TG 39531 control isoniazid	inbred	34	f	8-10wks	N=4	2011

Harrill1:41	Harrill1	histopathology	isoniazid	lymphohistiocytic, portal, multifocal infiltrate [score] lymphohistio_portal 39541 control isoniazid	inbred	34	f	8-10wks	N=4	2011

Harrill1:46	Harrill1	histopathology	isoniazid	hepatocytic cytoplasmic, microvesiculation, multifocal [score] microvesic_multi 39546 control isoniazid	inbred	34	f	8-10wks	N=4	2011

Harrill1:51	Harrill1	histopathology	isoniazid	hepatocytic cytoplasmic, microvesiculation, diffuse [score] microvesic_dif 39551 control isoniazid	inbred	34	f	8-10wks	N=4	2011

Harrill1:56	Harrill1	histopathology	isoniazid	hepatocytic hypertrophy, panlobular, diffuse [score] hypertro_pan 39556 control isoniazid	inbred	34	f	8-10wks	N=4	2011

Harrill2:41	Harrill2	organ weights	DB289	kidney (left) weight [g] Lt_kidney 44141 control DB289	inbred	34	f	6-8wks	N=5	2012

Harrill2:44	Harrill2	organ weights	DB289	kidney (right) weight [g] Rt_kidney 44144 control DB289	inbred	34	f	6-8wks	N=5	2012

Harrill2:48	Harrill2	organ weights	DB289	kidney (both) weight [g] both_kidney 44148 control DB289	inbred	34	f	6-8wks	N=5	2012

Harrill2:51	Harrill2	organ weights	DB289	total kidney weight as percentage of body weight [%] pctKW_BW 44151 control DB289 difference	inbred	34	f	6-8wks	N=5	2012

Harrill2:61	Harrill2	organ weights	DB289	liver weight at sacrifice [g] LW 44161 control DB289	inbred	34	f	6-8wks	N=5	2012

Harrill2:65	Harrill2	organ weights	DB289	liver weight as percentage of body weight [%] pctLW_BW 44165 control DB289 difference	inbred	34	f	6-8wks	N=5	2012

Hillebrands1:1	Hillebrands1	histopathology	(none)	number of perivascular immune cell clusters per renal cross-section [n] clusternum 51101	inbred	23	both	90wks	N=7	2014

Hillebrands1:2	Hillebrands1	histopathology	(none)	relative size of perivascular immune cell clusters [%] clustersize 51102	inbred	20	both	90wks	N=7	2014

Ishimori1:2	Ishimori1	organ weights	high-fat diet	liver weight [g] liver_wt 14002	QTL population		f	20wks	N=294	2004

JaxKOMP-EAP:446	JaxKOMP-EAP	organ weights	(none)	spleen weight [g] spleen_weight 100707	KOMP	132	both	18wks	N=2	2016

Jaxpheno2:20	Jaxpheno2	organ weights	(none)	liver weight [g] liver 22720 age 8wks age 16wks	inbred	11	both		N=8	2006

Jaxpheno2:22	Jaxpheno2	organ weights	(none)	liver weight as percentage of body weight [%] pct_liver 22722 age 8wks age 16wks	inbred	11	both		N=8	2006

Jaxpheno2:30	Jaxpheno2	organ weights	(none)	kidney (left) weight [g] kidney_L 22730 age 8wks age 16wks	inbred	11	both		N=8	2006

Jaxpheno2:32	Jaxpheno2	organ weights	(none)	kidney (right) weight [g] kidney_R 22732 age 8wks age 16wks	inbred	11	both		N=8	2006

Jaxpheno2:34	Jaxpheno2	organ weights	(none)	kidney (left) weight, as percentage of body weight [%] pct_kidney_L 22734 age 8wks age 16wks	inbred	11	both		N=8	2006

Jaxpheno2:36	Jaxpheno2	organ weights	(none)	kidney (right) weight, as percentage of body weight [%] pct_kidney_R 22736 age 8wks age 16wks	inbred	11	both		N=8	2006

Jaxpheno2:40	Jaxpheno2	organ weights	(none)	spleen weight [g] spleen 22740 age 8wks age 16wks	inbred	11	both		N=8	2006

Jaxpheno2:42	Jaxpheno2	organ weights	(none)	spleen weight, as percentage of body weight [%] pct_spleen 22742 age 8wks age 16wks	inbred	11	both		N=8	2006

Jaxpheno6:1	Jaxpheno6	immune cell quantification	(none)	splenic CD4 T cells (percentage of total viable cells) [%] pct_CD4 23101 8wks 16wks	inbred	11	both		N=9	2006

Jaxpheno6:3	Jaxpheno6	immune cell quantification	(none)	splenic CD8 T cells (percentage of total viable cells) [%] pct_CD8 23103 8wks 16wks	inbred	11	both		N=9	2006

Jaxpheno6:5	Jaxpheno6	immune cell quantification	(none)	splenic NK T cells (percentage of total viable cells) [%] pct_NKT 23105 8wks 16wks	inbred	11	both		N=9	2006

Jaxpheno6:7	Jaxpheno6	immune cell quantification	(none)	splenic NK cells (percentage of total viable cells) [%] pct_NK 23107 8wks 16wks	inbred	11	both		N=9	2006

Jaxpheno6:9	Jaxpheno6	immune cell quantification	(none)	splenic B cells (percentage of total viable cells) [%] pct_B 23109 8wks 16wks	inbred	11	both		N=9	2006

Jaxpheno6:20	Jaxpheno6	immune cell quantification	(none)	splenic granulocytes (percentage of total viable cells) [%] pct_Granu 23120 8wks 16wks	inbred	11	both		N=9	2006

Jaxpheno6:22	Jaxpheno6	immune cell quantification	(none)	splenic monocytes (percentage of total viable cells) [%] pct_Mono 23122 8wks 16wks	inbred	11	both		N=9	2006

Klaassen1:2	Klaassen1	histopathology	cadmium	cadmium-induced toxicity to liver [designation] liver 16402 categorical	inbred	8	m	8wks		2001

Korstanje2:1	Korstanje2	histopathology	(none)	percentage of glomeruli exhibiting mesangial matrix expansion [%] pct_MME 51001 6mo 12mo 20mo	inbred	29	m		N=6	2013

Lesage1:1	Lesage1	immune cell quantification	(none)	percentage of splenic lymphocytes that are CD3- [%] CD3_neg 63501	CC w/par	76	both	5-8wks	N=2	2018

Lesage1:2	Lesage1	immune cell quantification	(none)	percentage of splenic CD3- lymphocytes that are NK cells (CD49+ CD19-) [%] NK_cells_of_CD3_neg 63502	CC w/par	76	both	5-8wks	N=2	2018

Lesage1:3	Lesage1	immune cell quantification	(none)	percentage of splenic lymphocytes that are NK cells (CD49+ CD19-) [%] NK_cells_of_tot 63503	CC w/par	76	both	5-8wks	N=2	2018

Lesage1:4	Lesage1	immune cell quantification	(none)	percentage of splenic NK cells that are CD27- CD11b- [%] CD27_neg_CD11b_neg 63504	CC w/par	76	both	5-8wks	N=2	2018

Lesage1:5	Lesage1	immune cell quantification	(none)	percentage of splenic NK cells that are CD27+ CD11b- [%] CD27_pos_CD11b_neg 63505	CC w/par	76	both	5-8wks	N=2	2018

Lesage1:6	Lesage1	immune cell quantification	(none)	percentage of splenic NK cells that are CD27+ CD11b+ [%] CD27_pos_CD11b_pos 63506	CC w/par	76	both	5-8wks	N=2	2018

Lesage1:7	Lesage1	immune cell quantification	(none)	percentage of splenic NK cells that are CD27- CD11b+ [%] CD27_neg_CD11b_pos 63507	CC w/par	76	both	5-8wks	N=2	2018

Lesage1:8	Lesage1	immune cell quantification	(none)	percentage of splenic NK cells that are pre-mNK (B220+ CD11c+) [%] pre_mNK_of_NK 63508	CC w/par	76	both	5-8wks	N=2	2018

Lesage1:9	Lesage1	immune cell quantification	(none)	percentage of splenic lymphocytes that are pre-mNK (B220+ CD11c+) [%] pre_mNK_of_tot 63509	CC w/par	76	both	5-8wks	N=2	2018

Lesage1:10	Lesage1	immune cell quantification	(none)	percentage of splenic lymphocytes that are NK T cells (TCRb+ CD1d+) [%] NKT_cells 63510	CC w/par	76	both	5-8wks	N=2	2018

Lesage1:11	Lesage1	immune cell quantification	(none)	percentage of splenic NK T cells that are CD4+ CD8- [%] CD4_pos_CD8_neg_of_NKT 63511	CC w/par	76	both	5-8wks	N=2	2018

Lesage1:12	Lesage1	immune cell quantification	(none)	percentage of splenic lymphocytes that are CD4+ NK T cells [%] CD4_pos_CD8_neg_NKT_of_tot 63512	CC w/par	76	both	5-8wks	N=2	2018

Lesage1:13	Lesage1	immune cell quantification	(none)	percentage of splenic NK T cells that are CD4- CD8- [%] CD4_neg_CD8_neg_of_NKT 63513	CC w/par	76	both	5-8wks	N=2	2018

Lesage1:14	Lesage1	immune cell quantification	(none)	percentage of splenic lymphocytes that are CD4- CD8- NK T cells [%] CD4_neg_CD8_neg_NKT_of_tot 63514	CC w/par	76	both	5-8wks	N=2	2018

Lesage1:15	Lesage1	immune cell quantification	(none)	percentage of splenic lymphocytes that are T cells [%] T_cells 63515	CC w/par	76	both	5-8wks	N=2	2018

Lesage1:16	Lesage1	immune cell quantification	(none)	percentage of splenic T cells that are CD4+ CD8- [%] CD4_pos_CD8_neg_of_Tcells 63516	CC w/par	76	both	5-8wks	N=2	2018

Lesage1:17	Lesage1	immune cell quantification	(none)	percentage of splenic lymphocytes that are CD4+ T cells [%] CD4_pos_CD8_neg_of_tot 63517	CC w/par	76	both	5-8wks	N=2	2018

Lesage1:18	Lesage1	immune cell quantification	(none)	percentage of splenic T cells that are CD4- CD8+ [%] CD4_neg_CD8_pos_of_Tcells 63518	CC w/par	76	both	5-8wks	N=2	2018

Lesage1:19	Lesage1	immune cell quantification	(none)	percentage of splenic lymphocytes that are CD8+ T cells [%] CD4_neg_CD8_pos_of_tot 63519	CC w/par	76	both	5-8wks	N=2	2018

Lesage1:20	Lesage1	immune cell quantification	(none)	percentage of splenic T cells that are CD4- CD8- [%] CD4_neg_CD8_neg_of_Tcells 63520	CC w/par	76	both	5-8wks	N=2	2018

Lesage1:21	Lesage1	immune cell quantification	(none)	percentage of splenic lymphocytes that are CD4- CD8- T cells [%] CD4_neg_CD8_neg_of_tot 63521	CC w/par	76	both	5-8wks	N=2	2018

Lesage1:22	Lesage1	immune cell quantification	(none)	ratio of splenic CD4+ to CD8+ T cells [ratio] CD4_CD8_ratio 63522	CC w/par	76	both	5-8wks	N=2	2018

Lesage1:23	Lesage1	immune cell quantification	(none)	percentage of splenic leukocytes that are plasmacytoid dendritic cells [%] pDC 63523	CC w/par	74	both	5-8wks	N=2	2018

Lesage1:24	Lesage1	immune cell quantification	(none)	percentage of splenic leukocytes that are conventional dendritic cells [%] cDC 63524	CC w/par	74	both	5-8wks	N=2	2018

Lesage1:25	Lesage1	immune cell quantification	(none)	percentage of splenic conventional dendritic cells that are merocytic [%] mDC_of_cDC 63525	CC w/par	74	both	5-8wks	N=2	2018

Lesage1:26	Lesage1	immune cell quantification	(none)	percentage of splenic leukocytes that are merocytic dendritic cells [%] mDC_of_tot 63526	CC w/par	74	both	5-8wks	N=2	2018

Lesage1:27	Lesage1	immune cell quantification	(none)	percentage of splenic conventional dendritic cells that are cDC1 [%] cDC1_of_cDC 63527	CC w/par	74	both	5-8wks	N=2	2018

Lesage1:28	Lesage1	immune cell quantification	(none)	percentage of splenic leukocytes that are cDC1 conventional dendritic cells [%] cDC1_of_tot 63528	CC w/par	74	both	5-8wks	N=2	2018

Lesage1:29	Lesage1	immune cell quantification	(none)	percentage of splenic conventional dendritic cells that are cDC2 [%] cDC2_of_cDC 63529	CC w/par	74	both	5-8wks	N=2	2018

Lesage1:30	Lesage1	immune cell quantification	(none)	percentage of splenic leukocytes that are cDC2 conventional dendritic cells [%] cDC2_of_tot 63530	CC w/par	74	both	5-8wks	N=2	2018

Lesage2:9	Lesage2	immune cell quantification	(none)	total number of splenic lymphocytes (x 10⁶) [n] spleen_cells_tot 131924	CC w/par	76	both	5-8wks	N=2	2024

Lesage2:10	Lesage2	immune cell quantification	(none)	number of B cells in spleen (x 10⁶) [n] B_cells_tot 131925	CC w/par	76	both	5-8wks	N=2	2024

Lesage2:11	Lesage2	immune cell quantification	(none)	percentage of splenic lymphocytes that are B cells (CD3-CD49b-B220+CD19+) [%] B_cells_pct 131926	CC w/par	76	both	5-8wks	N=2	2024

Lyons1:1	Lyons1	organ weights	high-fat diet	liver weight [g] liver_wt 13001	QTL population		m	16-18wks	N=278	2003

Lyons1:2	Lyons1	histopathology	high-fat diet	gallstones, presence (score 0=absent, 1=present) [score] gallstone_presence 13002	QTL population		m	16-18wks	N=278	2003

Lyons1:3	Lyons1	histopathology	high-fat diet	gallstones, screening (score 0=absent, 1=present, 2=solid gallstones) [score] gallstone_score 13003	QTL population		m	16-18wks	N=278	2003

Lyons1:4	Lyons1	histopathology	high-fat diet	number of gallstones [n] gallstone_count 13004	QTL population		m	16-18wks	N=278	2003

Lyons1:5	Lyons1	histopathology	high-fat diet	weight of gallstones [mg] gallstone_weight 13005	QTL population		m	16-18wks	N=278	2003

Lyons1:6	Lyons1	histopathology	high-fat diet	sandy gallstones (score 0=absence, 1-4=severity) [score] gallstone_sandy 13006	QTL population		m	16-18wks	N=278	2003

Lyons1:7	Lyons1	histopathology	high-fat diet	solid gallstones (score 0=absence, 1-4=severity) [score] gallstone_solid 13007	QTL population		m	16-18wks	N=278	2003

Lyons1:8	Lyons1	histopathology	high-fat diet	cholesterol monohydrate crystals, aggregates (score 0=absence, 1-4=severity) [score] ChMC_agg 13008	QTL population		m	16-18wks	N=278	2003

Lyons1:9	Lyons1	histopathology	high-fat diet	cholesterol monohydrate crystals (score 0=absence, 1-4=severity) [score] ChMC_ind 13009	QTL population		m	16-18wks	N=278	2003

Lyons2:1	Lyons2	organ weights	high-fat diet	liver weight [g] liver_wt 13101	QTL population		m	16-18wks	N=277	2003

Lyons2:2	Lyons2	organ weights	high-fat diet	liver-to-bw ratio [ratio] liver_bw_ratio 13102	QTL population		m	16-18wks	N=277	2003

Lyons2:3	Lyons2	organ dimensions	high-fat diet	gallbladder, volume [µL] gallbladder_vol 13103	QTL population		m	16-18wks	N=277	2003

Lyons2:4	Lyons2	histopathology	high-fat diet	gallbladder, mucin (score 0-4) [score] gallbladder_mucin 13104	QTL population		m	16-18wks	N=277	2003

Lyons2:5	Lyons2	histopathology	high-fat diet	gallbladder bile characteristics (score 0=no crystals, 1=crystals present, 2=solid or sandy gallstones present) [score] bile_score 13105	QTL population		m	16-18wks	N=277	2003

Lyons2:6	Lyons2	histopathology	high-fat diet	cholesterol monohydrate crystals (score 0=absent, 1-4=increasing severity) [score] gallstone_crystals 13106	QTL population		m	16-18wks	N=277	2003

Lyons2:7	Lyons2	histopathology	high-fat diet	sandy gallstones (score 0=absence, 1-4=severity) [score] gallstone_sandy 13107	QTL population		m	16-18wks	N=277	2003

Lyons2:8	Lyons2	histopathology	high-fat diet	solid gallstones (score 0=absence, 1-5=severity) [score] gallstone_solid 13108	QTL population		m	16-18wks	N=277	2003

Lyons2:9	Lyons2	histopathology	high-fat diet	number of solid gallstones [n] gallstone_count 13109	QTL population		m	16-18wks	N=277	2003

Lyons2:10	Lyons2	histopathology	high-fat diet	weight of solid gallstones [mg] gallstone_weight 13110	QTL population		m	16-18wks	N=277	2003

Lyons2:14	Lyons2	histopathology	high-fat diet	solid gallstones, presence (score 0=absent, 1=present) [score] Solid 13114	QTL population		m	16-18wks	N=277	2003

Lyons3:1	Lyons3	histopathology	high-fat diet	weight of gallstones [mg] GS_wt 14601	QTL population		m	14-20wks	N=330	2004

Lyons3:2	Lyons3	histopathology	high-fat diet	number of gallstones [n] GS_no 14602	QTL population		m	14-20wks	N=330	2004

Lyons3:3	Lyons3	histopathology	high-fat diet	gallstone score (score 0=absent, 1=crystals only, 2=sandy or solid gallstones) [score] Score_1 14603	QTL population		m	14-20wks	N=330	2004

Lyons3:4	Lyons3	histopathology	high-fat diet	cholesterol monohydrate crystals, aggregates (score 0=absence, 1-4=severity) [score] AggChM 14604	QTL population		m	14-20wks	N=330	2004

Lyons3:5	Lyons3	histopathology	high-fat diet	solid gallstones (score 0=absence, 4=severity) [score] Solid 14605	QTL population		m	14-20wks	N=330	2004

Lyons3:6	Lyons3	histopathology	high-fat diet	sandy gallstones (score 0=absence, 1-4=severity) [score] Sandy 14606	QTL population		m	14-20wks	N=330	2004

Lyons3:7	Lyons3	histopathology	high-fat diet	gallbladder mucin accumulation (score 0-3) 0=no mucin;1-3= mucin accumulation severity [score] Mucin 14607	QTL population		m	14-20wks	N=330	2004

Lyons3:8	Lyons3	organ dimensions	high-fat diet	gallbladder volume [μL] GB_vol 14608	QTL population		m	14-20wks	N=330	2004

Mahler1:1	Mahler1	organ weights	(none)	spleen to body weight ratio, first Principal Component [ratio] SplBW 12101	QTL population		both	6wks	N=102	2002

Mahler1:2	Mahler1	histopathology	(none)	cecum assessment, first Principal Component CecumPC1 12102	QTL population		both	6wks	N=102	2002

Mahler1:3	Mahler1	histopathology	(none)	proximal colon assessment, first Principal Component ProxPC1 12103	QTL population		both	6wks	N=102	2002

Mahler1:4	Mahler1	histopathology	(none)	middle colon assessment, first Principal Component MidPC1 12104	QTL population		both	6wks	N=102	2002

Mahler1:5	Mahler1	histopathology	(none)	distal colon assessment, first Principal Component DistPC1 12105	QTL population		both	6wks	N=102	2002

Mahler1:6	Mahler1	histopathology	(none)	ulceration (score 0-4, increasing severity), first Principal Component Ulceration-PC1 12106	QTL population		both	6wks	N=102	2002

Mahler1:7	Mahler1	histopathology	(none)	ulceration (score 0-4, increasing severity), second Principal Component Ulceration-PC2 12107	QTL population		both	6wks	N=102	2002

Mills1:5	Mills1	apoptosis assessment	(none)	early apoptotic splenocytes [%] early_apoptotic 25205 6mo 12mo 20mo	inbred	30	both		N=3	2008

Mills1:11	Mills1	apoptosis assessment	(none)	late apoptotic splenocytes [%] late_apoptotic 25211 6mo 12mo 20mo	inbred	30	both		N=3	2008

Mills1:17	Mills1	apoptosis assessment	(none)	all apoptotic splenocytes [%] all_apoptotic 25217 6mo 12mo 20mo	inbred	30	both		N=3	2008

Mrug1:1	Mrug1	histopathology	(none)	mean of biliary duct number [n] mean_BDN 17501	QTL population		both	10d	N=230	2005

Mrug1:2	Mrug1	histopathology	(none)	mean of log(biliary duct number) [log(n)] mean_logBDN 17502	QTL population		both	1wk	N=230	2005

Mrug1:3	Mrug1	histopathology	(none)	cholangitis severity (score 0-4, increasing severity) 0 = no/minimal inflammation, 4=severe and extensive cholangiohepatitis [score] Cholangitis 17503	QTL population		both	10d	N=230	2005

Mrug1:4	Mrug1	organ dimensions	(none)	kidney length [mm] Klength 17504	QTL population		both	10d	N=230	2005

Mrug1:5	Mrug1	organ dimensions	(none)	kidney length, square root [sqrt(mm)] sqrtKL 17505	QTL population		both	10d	N=230	2005

Mrug1:6	Mrug1	organ dimensions	(none)	crown to rump length of kidney [mm] CRLength 17506	QTL population		both	10d	N=230	2005

Mrug1:7	Mrug1	organ dimensions	(none)	kidney weight/crown to rump length KL-CRL-Ratio 17507	QTL population		both	10d	N=230	2005

Mrug1:8	Mrug1	organ dimensions	(none)	kidney weight/crown to rump length, log transformed logKL-CRL-Ratio 17508	QTL population		both	10d	N=230	2005

Mrug1:9	Mrug1	organ weights	(none)	kidney weight [g] KW 17509	QTL population		both	10d	N=230	2005

Mrug1:10	Mrug1	organ weights	(none)	kidney weight, square root [sqrt(g)] sqrtKW 17510	QTL population		both	10d	N=230	2005

Mrug1:12	Mrug1	organ weights	(none)	kidney weight/body weight KW-BW-Ratio 17512	QTL population		both	10d	N=230	2005

Mrug1:13	Mrug1	organ weights	(none)	kidney weight/body weight, log transformed logKW-BW-ratio 17513	QTL population		both	10d	N=230	2005

Mrug1:14	Mrug1	organ dimensions	(none)	kidney volume [ml] KVolume 17514	QTL population		both	10d	N=230	2005

Mrug1:15	Mrug1	organ dimensions	(none)	kidney volume, square root [sqrt(ml)] sqrtKV 17515	QTL population		both	10d	N=230	2005

Mrug1:16	Mrug1	organ dimensions	(none)	renal principal component of kidney length, weight and volume Prin1 17516	QTL population		both	10d	N=230	2005

Nadeau2:11	Nadeau2	organ weights	high-fat high-sucrose diet	liver weight [g] liver_wt 53051	B6.A consomic w/par	24	m	21wks	N=39	2015

Nadeau2:12	Nadeau2	lipid profile	high-fat high-sucrose diet	liver triglycerides (mg/g liver) liver_TG 53052	B6.A consomic w/par	24	m	21wks	N=39	2015

Nadeau2:13	Nadeau2	lipid profile	high-fat high-sucrose diet	total liver triglycerides [g] liver_TG_tot 53053	B6.A consomic w/par	24	m	21wks	N=39	2015

Nadeau3:15	Nadeau3	organ weights	high-fat high-sucrose diet	liver weight after 16 wks on diet [g] liver_wt 114358 chow HFHS	inbred	2	m	21wks	N=17	2016

Nadeau3:17	Nadeau3	lipid profile	high-fat high-sucrose diet	liver triglycerides per mg liver after 16 wks on diet [mg/g] liver_TG 114360 chow HFHS	inbred	2	m	21wks	N=17	2016

Nadeau3:19	Nadeau3	lipid profile	high-fat high-sucrose diet	total liver triglycerides after 16 wks on diet [mg] liver_TG_tot 114362 chow HFHS	inbred	2	m	21wks	N=17	2016

Paigen1:7	Paigen1	organ weights	high-fat diet	liver weight at sacrifice [g] liverweight 2907	inbred	43	both	15-19wks	N=9	2000

Paigen1:8	Paigen1	organ dimensions	high-fat diet	gallbladder volume [µL] gbvol 2908	inbred	43	both	15-19wks	N=8	2000

Paigen1:9	Paigen1	histopathology	high-fat diet	gallbladder, mucin (score: 0-4) [score] mucin 2909	inbred	43	both	15-19wks	N=8	2000

Paigen1:10	Paigen1	histopathology	high-fat diet	gallbladder, arc (score: 0-4) [score] arc 2910	inbred	43	both	15-19wks	N=8	2000

Paigen1:11	Paigen1	histopathology	high-fat diet	gallbladder, filaments (score: 0-4) [score] filaments 2911	inbred	43	both	15-19wks	N=8	2000

Paigen1:12	Paigen1	histopathology	high-fat diet	gallbladder, small liquid crystals (score: 0-4) [score] smallLC 2912	inbred	43	both	15-19wks	N=8	2000

Paigen1:13	Paigen1	histopathology	high-fat diet	gallbladder, aggregated liquid crystals (score: 0-4) [score] agLC 2913	inbred	43	both	15-19wks	N=8	2000

Paigen1:14	Paigen1	histopathology	high-fat diet	gallbladder, fused liquid crystals (score: 0-4) [score] fusedLC 2914	inbred	43	both	15-19wks	N=8	2000

Paigen1:15	Paigen1	histopathology	high-fat diet	gallbladder, cholesterol monohydrate crystals (score: 0-4) [score] ChMC 2915	inbred	43	both	15-19wks	N=8	2000

Paigen1:16	Paigen1	histopathology	high-fat diet	gallbladder, number of sandy stones [n] sandysto 2916	inbred	43	both	15-19wks	N=8	2000

Paigen1:17	Paigen1	histopathology	high-fat diet	gallbladder, number of true gallstones [n] gs 2917	inbred	43	both	15-19wks	N=8	2000

Paigen1:18	Paigen1	histopathology	high-fat diet	gallbladder, number of sandy plus true stones [n] nstones 2918	inbred	43	both	15-19wks	N=8	2000

Paigen1:19	Paigen1	histopathology	high-fat diet	gallbladder, presence of stones (score: 1=present, 0=absent) [score] st_pres 2919	inbred	43	both	15-19wks	N=9	2000

Paigen1:26	Paigen1	lipid profile	high-fat diet	hepatic cholesterol concentration (free per g liver) [mg] freeHCC 2926	inbred	43	both	15-19wks	N=6	2000

Paigen1:27	Paigen1	lipid profile	high-fat diet	hepatic cholesterol concentration (esterified per g liver) [mg] estHCC 2927	inbred	43	both	15-19wks	N=6	2000

Paigen1:28	Paigen1	lipid profile	high-fat diet	hepatic cholesterol concentration (total per g liver) [mg] totHCC 2928	inbred	43	both	15-19wks	N=8	2000

Paigen1:29	Paigen1	lipid profile	high-fat diet	hepatic cholesterol concentration (free to esterified ratio) [ratio] free_to_est 2929	inbred	43	both	15-19wks	N=6	2000

Paigen1:30	Paigen1	histopathology	high-fat diet	liver microvacuoles (score: 0-4) [score] microvacs 2930	inbred	43	both	15-19wks	N=3	2000

Paigen1:31	Paigen1	histopathology	high-fat diet	liver macrovacuoles (score: 0-4) [score] macrovacs 2931	inbred	43	both	15-19wks	N=3	2000

Paigen1:32	Paigen1	histopathology	high-fat diet	liver inflammation (score: 0-4) [score] inflammation 2932	inbred	43	both	15-19wks	N=3	2000

Paigen3:7	Paigen3	organ weights	high-fat diet	liver weight at sacrifice [g] liverweight 2807	obesity mutants	8	both	15-19wks	N=20	2000

Paigen3:8	Paigen3	organ dimensions	high-fat diet	gallbladder volume [µL] gbvol 2808	obesity mutants	8	both	15-19wks	N=18	2000

Paigen3:9	Paigen3	histopathology	high-fat diet	gallbladder, mucin (score: 0-4) [score] mucin 2809	obesity mutants	7	both	15-19wks	N=8	2000

Paigen3:10	Paigen3	histopathology	high-fat diet	gallbladder, arc (score: 0-4) [score] arc 2810	obesity mutants	7	both	15-19wks	N=8	2000

Paigen3:11	Paigen3	histopathology	high-fat diet	gallbladder, filaments (score: 0-4) [score] filaments 2811	obesity mutants	7	both	15-19wks	N=8	2000

Paigen3:12	Paigen3	histopathology	high-fat diet	gallbladder, small liquid crystals (score: 0-4) [score] smallLC 2812	obesity mutants	7	both	15-19wks	N=8	2000

Paigen3:13	Paigen3	histopathology	high-fat diet	gallbladder, aggregated liquid crystals (score: 0-4) [score] agLC 2813	obesity mutants	7	both	15-19wks	N=8	2000

Paigen3:14	Paigen3	histopathology	high-fat diet	gallbladder, fused liquid crystals (score: 0-4) [score] fusedLC 2814	obesity mutants	7	both	15-19wks	N=8	2000

Paigen3:15	Paigen3	histopathology	high-fat diet	gallbladder, cholesterol monohydrate crystals (score: 0-4) [score] ChMC 2815	obesity mutants	7	both	15-19wks	N=8	2000

Paigen3:16	Paigen3	histopathology	high-fat diet	gallbladder, number of sandy stones [n] sandysto 2816	obesity mutants	7	both	15-19wks	N=8	2000

Paigen3:17	Paigen3	histopathology	high-fat diet	gallbladder, number of true gallstones [n] gs 2817	obesity mutants	7	both	15-19wks	N=8	2000

Paigen3:18	Paigen3	histopathology	high-fat diet	gallbladder, number of sandy plus true stones [n] nstones 2818	obesity mutants	7	both	15-19wks	N=8	2000

Paigen3:19	Paigen3	histopathology	high-fat diet	gallbladder, presence of stones (score: 1=present, 0=absent) [score] st_pres 2819	obesity mutants	8	both	15-19wks	N=19	2000

Paigen3:26	Paigen3	lipid profile	high-fat diet	hepatic cholesterol concentration (free per g liver) [mg] freeHCC 2826	obesity mutants	8	both	15-19wks	N=6	2000

Paigen3:27	Paigen3	lipid profile	high-fat diet	hepatic cholesterol concentration (esterified per g liver) [mg] estHCC 2827	obesity mutants	8	both	15-19wks	N=6	2000

Paigen3:28	Paigen3	lipid profile	high-fat diet	hepatic cholesterol concentration (total per g liver) [mg] totHCC 2828	obesity mutants	8	both	15-19wks	N=9	2000

Paigen3:29	Paigen3	lipid profile	high-fat diet	hepatic cholesterol concentration (free to esterified ratio) [ratio] free_to_est 2829	obesity mutants	8	both	15-19wks	N=6	2000

Paigen3:30	Paigen3	histopathology	high-fat diet	liver microvacuoles (score: 0-4) [score] microvacs 2830	obesity mutants	7	both	15-19wks	N=3	2000

Paigen3:31	Paigen3	histopathology	high-fat diet	liver macrovacuoles (score: 0-4) [score] macrovacs 2831	obesity mutants	7	both	15-19wks	N=3	2000

Paigen3:32	Paigen3	histopathology	high-fat diet	liver inflammation (score: 0-4) [score] inflammation 2832	obesity mutants	7	both	15-19wks	N=3	2000

Reed1:9	Reed1	organ weights	(none)	kidney weight [g] kidneys 32609 weight [g] as percent of body weight [%]	inbred	28	m	29-67wks	N=12	2009

Reed2:41	Reed2	organ weights	(none)	pancreas weight [g] pancreas_wt 53141	B6.129 and 129.B6 consomic w/par	9	both	26wks	N=17	2015

Reed2:46	Reed2	organ weights	(none)	kidney weight (both) [g] kidney_wt 53146	B6.129 and 129.B6 consomic w/par	9	both	26wks	N=17	2015

Reed2:51	Reed2	organ weights	(none)	liver weight [g] liver_wt 53151	B6.129 and 129.B6 consomic w/par	9	both	26wks	N=17	2015

Reed2:56	Reed2	organ weights	(none)	spleen weight [g] spleen_wt 53156	B6.129 and 129.B6 consomic w/par	9	both	26wks	N=17	2015

Rodriguez1:1	Rodriguez1	in vitro assay	(none)	spleen and liver murine cytomegalovirus genome levels (normalized to endogenous b-actin) [ratio] CMV_LEVELS 24101	QTL population		both	8-12wks	N=92	2009

Rusyn5:11	Rusyn5	organ weights	high-fat diet and ethanol	liver weight as a percent of body weight [%] pctLW_BW 43011 high-fat only high-fat and ethanol	inbred	14	m	8-14wks	N=3	2011

Rusyn5:13	Rusyn5	histopathology	high-fat diet and ethanol	liver steatosis (0-4) [score] steatosis 43013 high-fat only high-fat and ethanol	inbred	14	m	8-14wks	N=3	2011

Rusyn5:15	Rusyn5	histopathology	high-fat diet and ethanol	liver inflammation (0-2) [score] inflammation 43015 high-fat only high-fat and ethanol	inbred	14	m	8-14wks	N=3	2011

Rusyn5:17	Rusyn5	histopathology	high-fat diet and ethanol	liver necrosis (0-2) [score] necrosis 43017 high-fat only high-fat and ethanol	inbred	14	m	8-14wks	N=3	2011

Rusyn5:19	Rusyn5	histopathology	high-fat diet and ethanol	total liver histopathology (0-8) [score] total_pathology 43019 high-fat only high-fat and ethanol	inbred	14	m	8-14wks	N=3	2011

Rusyn5:21	Rusyn5	lipid profile	high-fat diet and ethanol	hepatic triglycerides (TG) [mg/g] liver_TG 43021 high-fat only high-fat and ethanol	inbred	6	m	8-14wks	N=3	2011

Rusyn5:23	Rusyn5	metabolite quantification	high-fat diet and ethanol	reduced liver glutathione (GSH) [nmol/mg] liver_GSH 43023 high-fat only high-fat and ethanol	inbred	14	m	8-14wks	N=3	2011

Rusyn5:25	Rusyn5	metabolite quantification	high-fat diet and ethanol	oxidized liver glutathione (GSSG) [nmol/mg] liver_GSSG 43025 high-fat only high-fat and ethanol	inbred	14	m	8-14wks	N=3	2011

Rusyn5:29	Rusyn5	metabolite quantification	high-fat diet and ethanol	ratio of reduced to oxidized liver glutathione [ratio] liver_GSHratio 43029 high-fat only high-fat and ethanol	inbred	14	m	8-14wks	N=3	2011

Rusyn5:31	Rusyn5	metabolite quantification	high-fat diet and ethanol	liver homocysteine [nmol/mg] liver_homocysteine 43031 high-fat only high-fat and ethanol	inbred	14	m	8-14wks	N=3	2011

Rusyn5:33	Rusyn5	metabolite quantification	high-fat diet and ethanol	liver S-adenosylhomocysteine (SAH) [nmol/mg] liver_SAH 43033 high-fat only high-fat and ethanol	inbred	14	m	8-14wks	N=3	2011

Rusyn5:35	Rusyn5	metabolite quantification	high-fat diet and ethanol	liver methionine [nmol/mg] liver_methionine 43035 high-fat only high-fat and ethanol	inbred	14	m	8-14wks	N=3	2011

Rusyn5:37	Rusyn5	metabolite quantification	high-fat diet and ethanol	liver S-adenosylmethionine (SAM) [nmol/mg] liver_SAM 43037 high-fat only high-fat and ethanol	inbred	14	m	8-14wks	N=3	2011

Rusyn5:39	Rusyn5	metabolite quantification	high-fat diet and ethanol	ratio of liver SAM to SAH (SAM/SAH) [ratio] liver_SAM_SAH 43039 high-fat only high-fat and ethanol	inbred	14	m	8-14wks	N=3	2011

Rusyn5:42	Rusyn5	metabolite quantification	high-fat diet and ethanol	liver BHMT, protein expression relative to high-fat-only group [%] liver_BHMT_hfe 43042	inbred	14	m	8-14wks	N=3	2011

Rusyn5:44	Rusyn5	metabolite quantification	high-fat diet and ethanol	liver DDIT3 (formerly CHOP), protein expression relative to high-fat-only group [%] liver_DDIT3_hfe 43044	inbred	14	m	8-14wks	N=3	2011

Rusyn5:46	Rusyn5	metabolite quantification	high-fat diet and ethanol	liver HSPA5 (formerly GRP78), protein expression relative to high-fat-only group [%] liver_HSPA5_hfe 43046	inbred	14	m	8-14wks	N=3	2011

Rusyn5:48	Rusyn5	metabolite quantification	high-fat diet and ethanol	liver SREBF1 (formerly NSREBP1), protein expression relative to high-fat-only group [%] liver_SREBF1_hfe 43048	inbred	14	m	8-14wks	N=3	2011

Rusyn5:50	Rusyn5	RNA expression profiling	high-fat diet and ethanol	liver Acox1, mRNA abundance relative to high-fat-only group [%] liver_Acox1_hfe 43050	inbred	6	m	8-14wks	N=3	2011

Rusyn5:52	Rusyn5	RNA expression profiling	high-fat diet and ethanol	liver Adipor2, mRNA abundance relative to high-fat-only group [%] liver_Adipor2_hfe 43052	inbred	6	m	8-14wks	N=3	2011

Rusyn5:54	Rusyn5	RNA expression profiling	high-fat diet and ethanol	liver Ahcy, mRNA abundance relative to high-fat-only group [%] liver_Ahcy_hfe 43054	inbred	14	m	8-14wks	N=3	2011

Rusyn5:56	Rusyn5	RNA expression profiling	high-fat diet and ethanol	liver Cbs, mRNA abundance relative to high-fat-only group [%] liver_Cbs_hfe 43056	inbred	14	m	8-14wks	N=3	2011

Rusyn5:58	Rusyn5	RNA expression profiling	high-fat diet and ethanol	liver Cebpa, mRNA abundance relative to high-fat-only group [%] liver_Cebpa_hfe 43058	inbred	14	m	8-14wks	N=3	2011

Rusyn5:60	Rusyn5	RNA expression profiling	high-fat diet and ethanol	liver Cth, mRNA abundance relative to high-fat-only group [%] liver_Cth_hfe 43060	inbred	14	m	8-14wks	N=3	2011

Rusyn5:62	Rusyn5	RNA expression profiling	high-fat diet and ethanol	liver Ddit3 (formerly Chop), mRNA abundance relative to high-fat-only group [%] liver_Ddit3_hfe 43062	inbred	14	m	8-14wks	N=3	2011

Rusyn5:64	Rusyn5	RNA expression profiling	high-fat diet and ethanol	liver Gnmt, mRNA abundance relative to high-fat-only group [%] liver_Gnmt_hfe 43064	inbred	14	m	8-14wks	N=3	2011

Rusyn5:66	Rusyn5	RNA expression profiling	high-fat diet and ethanol	liver Mat1a, mRNA abundance relative to high-fat-only group [%] liver_Mat1a_hfe 43066	inbred	14	m	8-14wks	N=3	2011

Rusyn5:68	Rusyn5	RNA expression profiling	high-fat diet and ethanol	liver Mthfr, mRNA abundance relative to high-fat-only group [%] liver_Mthfr_hfe 43068	inbred	14	m	8-14wks	N=3	2011

Rusyn5:70	Rusyn5	RNA expression profiling	high-fat diet and ethanol	liver Mtr, mRNA abundance relative to high-fat-only group [%] liver_Mtr_hfe 43070	inbred	14	m	8-14wks	N=3	2011

Rusyn5:72	Rusyn5	RNA expression profiling	high-fat diet and ethanol	liver Mttp, mRNA abundance relative to high-fat-only group [%] liver_Mttp_hfe 43072	inbred	6	m	8-14wks	N=3	2011

Rusyn5:74	Rusyn5	RNA expression profiling	high-fat diet and ethanol	liver Srebf1, mRNA abundance relative to high-fat-only group [%] liver_Srebf1_hfe 43074	inbred	14	m	8-14wks	N=3	2011

Rusyn6:11	Rusyn6	organ weights	trichloroethylene	liver weight as a percent of body weight [%] liver_adj 51211 control TCE	inbred	7	m	6-7wks	N=4	2014

Rusyn6:14	Rusyn6	histopathology	trichloroethylene	BrdU-positive nuclei in liver (hepatocellular proliferation), relative to control group [%] BrdU_liver_tce 51214	inbred	7	m	6-7wks	N=3	2014

Rusyn6:16	Rusyn6	drug and metabolite quantification	trichloroethylene	trichloroacetic acid (liver TCA) [nmol/g] TCA_liver_tce 51216	inbred	7	m	6-7wks	N=4	2014

Rusyn6:18	Rusyn6	drug and metabolite quantification	trichloroethylene	dichloroacetic acid (liver DCA) [nmol/g] DCA_liver_tce 51218	inbred	7	m	6-7wks	N=4	2014

Rusyn6:20	Rusyn6	drug and metabolite quantification	trichloroethylene	trichloroethanol (liver TCOH) [nmol/g] TCOH_liver_tce 51220	inbred	7	m	6-7wks	N=4	2014

Rusyn6:22	Rusyn6	drug and metabolite quantification	trichloroethylene	S-(1,2-dichlorovinyl) glutathione (liver DCVG) [pmol/g] DCVG_liver_tce 51222	inbred	7	m	6-7wks	N=4	2014

Rusyn6:26	Rusyn6	RNA expression profiling	trichloroethylene	Acox1, mRNA in liver, relative to control group [ratio] Acox1_liver_tce 51226	inbred	7	m	6-7wks	N=3	2014

Rusyn6:28	Rusyn6	RNA expression profiling	trichloroethylene	Cyp4a10, mRNA in liver, relative to control group [ratio] Cyp4a10_liver_tce 51228	inbred	7	m	6-7wks	N=3	2014

Rusyn6:30	Rusyn6	RNA expression profiling	trichloroethylene	Ppara, mRNA in liver, relative to control group [ratio] Ppara_liver_tce 51230	inbred	7	m	6-7wks	N=3	2014

Rusyn6:51	Rusyn6	organ weights	trichloroethylene	kidney weight as a percent of body weight [%] kidney_adj 51251 control TCE	inbred	7	m	6-7wks	N=4	2014

Rusyn6:54	Rusyn6	histopathology	trichloroethylene	BrdU-positive nuclei in kidney (proximal tubule cell proliferation), relative to control group [%] BrdU_kidney_tce 51254	inbred	7	m	6-7wks	N=3	2014

Rusyn6:55	Rusyn6	histopathology	trichloroethylene	kidney injury molecule 1 (KIM-1) positive proximal tubules [%] KIM1_kidney 51255 control TCE	inbred	7	m	6-7wks	N=4	2014

Rusyn6:58	Rusyn6	drug and metabolite quantification	trichloroethylene	trichloroacetic acid (kidney TCA) [nmol/g] TCA_kidney_tce 51258	inbred	7	m	6-7wks	N=4	2014

Rusyn6:60	Rusyn6	drug and metabolite quantification	trichloroethylene	dichloroacetic acid (kidney DCA) [nmol/g] DCA_kidney_tce 51260	inbred	6	m	6-7wks	N=3	2014

Rusyn6:62	Rusyn6	drug and metabolite quantification	trichloroethylene	trichloroethanol (kidney TCOH) [nmol/g] TCOH_kidney_tce 51262	inbred	7	m	6-7wks	N=4	2014

Rusyn6:64	Rusyn6	drug and metabolite quantification	trichloroethylene	S-(1,2-dichlorovinyl) glutathione (kidney DCVG) [pmol/g] DCVG_kidney_tce 51264	inbred	6	m	6-7wks	N=2	2014

Rusyn6:66	Rusyn6	drug and metabolite quantification	trichloroethylene	S-(1,2-dichlorovinyl)-L-cysteine (kidney DCVC) [pmol/g] DCVC_kidney_tce 51266	inbred	6	m	6-7wks	N=2	2014

Rusyn6:68	Rusyn6	RNA expression profiling	trichloroethylene	Acox1, mRNA in kidney, relative to control group [ratio] Acox1_kidney_tce 51268	inbred	7	m	6-7wks	N=3	2014

Rusyn6:70	Rusyn6	RNA expression profiling	trichloroethylene	Cyp4a10, mRNA in kidney, relative to control group [ratio] Cyp4a10_kidney_tce 51270	inbred	7	m	6-7wks	N=3	2014

Schonfeld1:22	Schonfeld1	lipid profile	(none)	hepatic triglycerides (5h fast) [mg/g] hTG 32348	inbred	11	both	9-13wks	N=6	2005

Schonfeld1:25	Schonfeld1	organ weights	(none)	liver weight [g] LW 32361	inbred	11	both	9-13wks	N=6	2005

Schonfeld1:26	Schonfeld1	organ weights	(none)	liver weight as a percent of body weight [%] LW_BW 32362	inbred	11	both	9-13wks	N=6	2005

Schoonjans1:177	Schoonjans1	biomarker quantification	high-fat diet	bile acid 3-oxocholic acid amount in liver, at 29 wks [ng/mL] oxo_CA_liver 112808 CD	BXD w/par	2	m	29wks	N=1	2021

Schoonjans1:178	Schoonjans1	biomarker quantification	high-fat diet	bile acid 7-ketodeoxycholic acid amount in liver, at 29 wks [ng/mL] keto_DCA_liver 112809 CD HFD	BXD w/par	12	m	29wks	N=2	2021

Schoonjans1:180	Schoonjans1	biomarker quantification	high-fat diet	bile acid α-muricholic acid amount in liver, at 29 wks [ng/mL] aMCA_liver 112812 CD HFD	BXD w/par	36	m	29wks	N=3	2021

Schoonjans1:182	Schoonjans1	biomarker quantification	high-fat diet	bile acid β-muricholic acid amount in liver, at 29 wks [ng/mL] bMCA_liver 112814 CD HFD	BXD w/par	36	m	29wks	N=5	2021

Schoonjans1:184	Schoonjans1	biomarker quantification	high-fat diet	bile acid cholic acid amount in liver, at 29 wks [ng/mL] CA_liver 112816 CD HFD	BXD w/par	36	m	29wks	N=5	2021

Schoonjans1:186	Schoonjans1	biomarker quantification	high-fat diet	bile acid chenodeoxycholic acid amount in liver, at 29 wks [ng/mL] CDCA_liver 112818 CD HFD	BXD w/par	36	m	29wks	N=5	2021

Schoonjans1:188	Schoonjans1	biomarker quantification	high-fat diet	bile acid deoxycholic acid amount in liver, at 29 wks [ng/mL] DCA_liver 112820 CD HFD	BXD w/par	36	m	29wks	N=5	2021

Schoonjans1:190	Schoonjans1	biomarker quantification	high-fat diet	bile acid glycocholic acid amount in liver, at 29 wks [ng/mL] GCA_liver 112822 CD HFD	BXD w/par	36	m	29wks	N=5	2021

Schoonjans1:192	Schoonjans1	biomarker quantification	high-fat diet	bile acid glycochenodeoxycholic acid amount in liver, at 29 wks [ng/mL] GCDCA_liver 112824 CD HFD	BXD w/par	3	m	29wks	N=1	2021

Schoonjans1:194	Schoonjans1	biomarker quantification	high-fat diet	bile acid glycolithocholic acid amount in liver, at 29 wks [ng/mL] GLCA_liver 112827 CD HFD	BXD w/par	3	m	29wks	N=1	2021

Schoonjans1:196	Schoonjans1	biomarker quantification	high-fat diet	bile acid glycoursodeoxycholic acid amount in liver, at 29 wks [ng/mL] GUDCA_liver 112829 CD HFD	BXD w/par	34	m	29wks	N=3	2021

Schoonjans1:198	Schoonjans1	biomarker quantification	high-fat diet	bile acid isodeoxycholic acid amount in liver, at 29 wks [ng/mL] IsoDCA_liver 112831 CD HFD	BXD w/par	36	m	29wks	N=5	2021

Schoonjans1:200	Schoonjans1	biomarker quantification	high-fat diet	bile acid murocholic acid amount in liver, at 29 wks [ng/mL] MDCA_liver 112833 CD HFD	BXD w/par	10	m	29wks	N=1	2021

Schoonjans1:202	Schoonjans1	biomarker quantification	high-fat diet	bile acid tauro-α-muricholic acid amount in liver, at 29 wks [ng/mL] TaMCA_liver 112835 CD HFD	BXD w/par	36	m	29wks	N=5	2021

Schoonjans1:204	Schoonjans1	biomarker quantification	high-fat diet	bile acid tauro-β-muricholic acid amount in liver, at 29 wks [ng/mL] TbMCA_liver 112837 CD HFD	BXD w/par	36	m	29wks	N=5	2021

Schoonjans1:206	Schoonjans1	biomarker quantification	high-fat diet	bile acid taurocholic acid amount in liver, at 29 wks [ng/mL] TCA_liver 112839 CD HFD	BXD w/par	36	m	29wks	N=5	2021

Schoonjans1:208	Schoonjans1	biomarker quantification	high-fat diet	bile acid taurochenodeoxycholic acid amount in liver, at 29 wks [ng/mL] TCDCA_liver 112841 CD HFD	BXD w/par	36	m	29wks	N=5	2021

Schoonjans1:210	Schoonjans1	biomarker quantification	high-fat diet	bile acid taurodeoxycholic acid amount in liver, at 29 wks [ng/mL] TDCA_liver 112843 CD HFD	BXD w/par	36	m	29wks	N=5	2021

Schoonjans1:212	Schoonjans1	biomarker quantification	high-fat diet	bile acid taurohyodeoxycholic acid amount in liver, at 29 wks [ng/mL] THDCA_liver 112845 CD HFD	BXD w/par	36	m	29wks	N=5	2021

Schoonjans1:214	Schoonjans1	biomarker quantification	high-fat diet	bile acid taurolithocholic acid amount in liver, at 29 wks [ng/mL] TLCA_liver 112847 CD HFD	BXD w/par	23	m	29wks	N=3	2021

Schoonjans1:216	Schoonjans1	biomarker quantification	high-fat diet	bile acid tauroursodeoxycholic acid amount in liver, at 29 wks [ng/mL] TUDCA_liver 112849 CD HFD	BXD w/par	36	m	29wks	N=5	2021

Schoonjans1:218	Schoonjans1	biomarker quantification	high-fat diet	bile acid ω-muricholic acid amount in liver, at 29 wks [ng/mL] wMCA_liver 112853 CD HFD	BXD w/par	36	m	29wks	N=5	2021

Schoonjans1:220	Schoonjans1	organ weights	high-fat diet	liver weight [g] liver_wt 112855 CD HFD	BXD w/par	36	m	29wks	N=5	2021

Schoonjans1:222	Schoonjans1	organ weights	high-fat diet	spleen weight [g] spleen_wt 112857 CD HFD	BXD w/par	35	m	29wks	N=5	2021

Schoonjans1:224	Schoonjans1	organ weights	high-fat diet	kidney weight (both) [g] kidney_wt 112859 CD HFD	BXD w/par	36	m	29wks	N=5	2021

Schoonjans1:234	Schoonjans1	organ weights	high-fat diet	cecum weight [g] cecum_wt 112869 CD HFD	BXD w/par	36	m	29wks	N=5	2021

Schoonjans1:236	Schoonjans1	organ dimensions	high-fat diet	small intestine length [cm] small_intestine_length 112871 CD HFD	BXD w/par	36	m	29wks	N=5	2021

Shorter8:2	Shorter8	organ weights	(none)	kidney weight, right [g] kidney_wt 110157	DO population		m	12-15wks	N=147	2019

Solberg1:15	Solberg1	organ weights	(none)	adrenal weight [g] adrenalwt 15015	QTL population		both	17wks	N=243	2004

Sunde1:11	Sunde1	RNA expression profiling	selenium	liver Dio1, mRNA abundance relative to C57BL/6J +Se [%] Dio1_mRNA 65311 Se deficient Se sufficient	inbred w/CC8	8	m	11-14wks	N=1	2018

Sunde1:13	Sunde1	RNA expression profiling	selenium	liver Gpx1, mRNA abundance relative to C57BL/6J +Se [%] Gpx1_mRNA 65313 Se deficient Se sufficient	inbred w/CC8	8	m	11-14wks	N=1	2018

Sunde1:15	Sunde1	RNA expression profiling	selenium	liver Gpx3, mRNA abundance relative to C57BL/6J +Se [%] Gpx3_mRNA 65315 Se deficient Se sufficient	inbred w/CC8	8	m	11-14wks	N=1	2018

Sunde1:17	Sunde1	RNA expression profiling	selenium	liver Gpx4, mRNA abundance relative to C57BL/6J +Se [%] Gpx4_mRNA 65317 Se deficient Se sufficient	inbred w/CC8	8	m	11-14wks	N=1	2018

Sunde1:19	Sunde1	RNA expression profiling	selenium	liver Msrb1, mRNA abundance relative to C57BL/6J +Se [%] Msrb1_mRNA 65319 Se deficient Se sufficient	inbred w/CC8	8	m	11-14wks	N=1	2018

Sunde1:21	Sunde1	RNA expression profiling	selenium	liver Selenof, mRNA abundance relative to C57BL/6J +Se [%] Selenof_mRNA 65321 Se deficient Se sufficient	inbred w/CC8	8	m	11-14wks	N=1	2018

Sunde1:23	Sunde1	RNA expression profiling	selenium	liver Selenoh, mRNA abundance relative to C57BL/6J +Se [%] Selenoh_mRNA 65323 Se deficient Se sufficient	inbred w/CC8	8	m	11-14wks	N=1	2018

Sunde1:25	Sunde1	RNA expression profiling	selenium	liver Selenok, mRNA abundance relative to C57BL/6J +Se [%] Selenok_mRNA 65325 Se deficient Se sufficient	inbred w/CC8	8	m	11-14wks	N=1	2018

Sunde1:27	Sunde1	RNA expression profiling	selenium	liver Selenom, mRNA abundance relative to C57BL/6J +Se [%] Selenom_mRNA 65327 Se deficient Se sufficient	inbred w/CC8	8	m	11-14wks	N=1	2018

Sunde1:29	Sunde1	RNA expression profiling	selenium	liver Selenon, mRNA abundance relative to C57BL/6J +Se [%] Selenon_mRNA 65329 Se deficient Se sufficient	inbred w/CC8	8	m	11-14wks	N=1	2018

Sunde1:31	Sunde1	RNA expression profiling	selenium	liver Selenoo, mRNA abundance relative to C57BL/6J +Se [%] Selenoo_mRNA 65331 Se deficient Se sufficient	inbred w/CC8	8	m	11-14wks	N=1	2018

Sunde1:33	Sunde1	RNA expression profiling	selenium	liver Selenop, mRNA abundance relative to C57BL/6J +Se [%] Selenop_mRNA 65333 Se deficient Se sufficient	inbred w/CC8	8	m	11-14wks	N=1	2018

Sunde1:35	Sunde1	RNA expression profiling	selenium	liver Selenos, mRNA abundance relative to C57BL/6J +Se [%] Selenos_mRNA 65335 Se deficient Se sufficient	inbred w/CC8	8	m	11-14wks	N=1	2018

Sunde1:37	Sunde1	RNA expression profiling	selenium	liver Selenot, mRNA abundance relative to C57BL/6J +Se [%] Selenot_mRNA 65337 Se deficient Se sufficient	inbred w/CC8	8	m	11-14wks	N=1	2018

Sunde1:39	Sunde1	RNA expression profiling	selenium	liver Selenow, mRNA abundance relative to C57BL/6J +Se [%] Selenow_mRNA 65339 Se deficient Se sufficient	inbred w/CC8	8	m	11-14wks	N=1	2018

Sunde1:41	Sunde1	RNA expression profiling	selenium	liver Txnrd1, mRNA abundance relative to C57BL/6J +Se [%] Txnrd1_mRNA 65341 Se deficient Se sufficient	inbred w/CC8	8	m	11-14wks	N=1	2018

Sunde1:43	Sunde1	RNA expression profiling	selenium	liver Txnrd2, mRNA abundance relative to C57BL/6J +Se [%] Txnrd2_mRNA 65343 Se deficient Se sufficient	inbred w/CC8	8	m	11-14wks	N=1	2018

Sunde1:45	Sunde1	RNA expression profiling	selenium	liver Txnrd3, mRNA abundance relative to C57BL/6J +Se [%] Txnrd3_mRNA 65345 Se deficient Se sufficient	inbred w/CC8	8	m	11-14wks	N=1	2018

Sunde1:47	Sunde1	protein activity assessment	selenium	liver Gpx1 enzyme activity (EU/g protein) [EU/g] Gpx1_act_liv 65347 Se deficient Se sufficient	inbred w/CC8	8	m	11-14wks	N=1	2018

Sunde1:53	Sunde1	protein activity assessment	selenium	liver Gpx4 enzyme activity (EU/g protein) [EU/g] Gpx4_act 65353 Se deficient Se sufficient	inbred w/CC8	8	m	11-14wks	N=1	2018

Sunde1:55	Sunde1	protein activity assessment	selenium	liver Txnrd enzyme activity (EU/g protein) [EU/g] Txnrd_act 65355 Se deficient Se sufficient	inbred w/CC8	8	m	11-14wks	N=1	2018

Threadgill1:1	Threadgill1	organ weights	acetaminophen	liver weight 24h after treatment [g] liverwt 19401 dose (mg/kg): control 100 200 300	inbred w/CC7	37	m	8-17wks	N=4	2005

Threadgill1:4	Threadgill1	histopathology	acetaminophen	necrosis [%] liver_necrosis 19404 dose (mg/kg): control 100 200 300	inbred w/CC7	37	m	8-17wks	N=2	2005

Threadgill1:14	Threadgill1	metabolite quantification	acetaminophen	reduced glutathione (GSH) [µmol/g] GSH 19414 control post-Rx 300mg/kg	inbred w/CC7	36	m	8-17wks	N=2	2005

Threadgill1:16	Threadgill1	metabolite quantification	acetaminophen	oxidized glutathione (GSSG) [µmol/g] GSSG 19416 control post-Rx 300mg/kg	inbred w/CC7	36	m	8-17wks	N=2	2005

Threadgill1:18	Threadgill1	metabolite quantification	acetaminophen	total glutathione (GSH plus GSSG) [µmol/g] GSH_total 19418 control post-Rx 300 mg/kg	inbred w/CC7	36	m	8-17wks	N=2	2005

Threadgill1:20	Threadgill1	metabolite quantification	acetaminophen	ratio of reduced (GSH) to oxidized (GSSG) glutathione [ratio] GSHratio 19420 control post-Rx 300mg/kg	inbred w/CC7	36	m	8-17wks	N=2	2005

Threadgill1:82	Threadgill1	metabolic panel	acetaminophen	catalase [µg/mL] catalase 19482 control post-Rx 300 mg/kg	inbred w/CC7	37	m	8-12wks	N=2	2005

Threadgill1:83	Threadgill1	biomarker quantification	acetaminophen	cytochrome P450 1A2 isoform [pmol/mg] CYP1A2 19483 control post-Rx 300 mg/kg	inbred w/CC7	37	m	8-12wks	N=2	2005

Threadgill1:84	Threadgill1	biomarker quantification	acetaminophen	cytochrome P450 2E1 isoform [pmol/mg] CYP2E1 19484 control post-Rx 300 mg/kg	inbred w/CC7	37	m	8-12wks	N=2	2005

Threadgill1:86	Threadgill1	metabolite quantification	acetaminophen	glutathione transferase [µg/mL] GSTpi 19486 control post-Rx 300 mg/kg	inbred w/CC7	37	m	8-12wks	N=2	2005

Threadgill2:3	Threadgill2	histopathology	acetaminophen	liver necrosis score [%] liver_necrosis 39603	inbred	5	m	6-8wks	N=5	2005

Threadgill2:4	Threadgill2	histopathology	acetaminophen	percent nitrotyrosine staining (marker of hepatocyte injury) [%] pct_nitrotyrosine 39604	inbred	5	m	6-8wks	N=5	2005

Threadgill2:5	Threadgill2	metabolite quantification	acetaminophen	reduced glutathione (GSH) [µmol/mg] GSH 39605 control post-Rx 300 mg/kg	inbred	5	m	6-8wks	N=4	2005

Threadgill2:6	Threadgill2	metabolite quantification	acetaminophen	percent reduced glutathione [%] GSH_pct 39606 control post-Rx 300 mg/kg	inbred	5	m	6-8wks	N=4	2005

Threadgill2:7	Threadgill2	metabolite quantification	acetaminophen	total glutathione [µmol/mg] GSH_total 39607 control post-Rx 300 mg/kg	inbred	5	m	6-8wks	N=4	2005

Vulpe1:1	Vulpe1	mineral quantification	(none)	copper (Cu) content in liver, dry weight [µg/g] copper 36801	inbred	18	both	8wks	N=6	2010

Vulpe1:2	Vulpe1	mineral quantification	(none)	iron (Fe) content in liver, dry weight [µg/g] iron 36802	inbred	18	both	8wks	N=6	2010

Vulpe1:3	Vulpe1	mineral quantification	(none)	zinc (Zn) content in liver, dry weight [µg/g] zinc 36803	inbred	18	both	8wks	N=6	2010

Williams1:1	Williams1	immune cell quantification	(none)	CD4 Treg cells (CD25+ CD44^int; as percentage of lymphocytes) [%] Treg 42901	inbred	5	f	8wks	N=3	2012

Williams1:2	Williams1	immune cell quantification	(none)	CD4 Treg cells (CD25+ CD44^int; as percentage of CD4 T cells) [%] Treg_adj 42902	inbred	5	f	8wks	N=3	2012

Williams1:3	Williams1	immune cell quantification	(none)	memory-effector CD4 T cells (CD25^- CD44^hi; as percentage of lymphocytes) [%] memoryT 42903	inbred	5	f	8wks	N=3	2012

Williams1:4	Williams1	immune cell quantification	(none)	memory-effector CD4 T cells (CD25^- CD44^hi; as percentage of CD4 T cells) [%] memoryT_adj 42904	inbred	5	f	8wks	N=3	2012

Williams1:5	Williams1	immune cell quantification	(none)	naive CD4 T cells (CD25^- CD44^lo; as percentage of lymphocytes) [%] naiveT 42905	inbred	5	f	8wks	N=3	2012

Williams1:6	Williams1	immune cell quantification	(none)	naive CD4 T cells (CD25^- CD44^lo; as percentage of CD4 T cells) [%] naiveT_adj 42906	inbred	5	f	8wks	N=3	2012

Wiltshire4:1	Wiltshire4	immune cell quantification	BEZ235	B cells, percent viability [%] Bcells_BEZ 52401 dose [µM]: control 0.046 0.137 1.235 11.1 100	inbred w/CC7	34	m	10wks	N=4	2015

Wiltshire4:7	Wiltshire4	immune cell quantification	BEZ235	T cells, percent viability [%] Tcells_BEZ 52407 dose [µM]: control 0.046 0.137 1.235 11.1 100	inbred w/CC7	34	m	10wks	N=4	2015

Wiltshire4:13	Wiltshire4	immune cell quantification	BEZ235	monocytes, percent viability [%] monocytes_BEZ 52413 dose [µM]: control 0.046 0.137 1.235 11.1 100	inbred w/CC7	34	m	10wks	N=4	2015

Wiltshire4:21	Wiltshire4	immune cell quantification	doxorubicin	B cells, percent viability [%] Bcells_Dox 52421 dose [µM]: control 0.046 0.137 1.235 11.1 100	inbred w/CC7	35	m	10wks	N=4	2015

Wiltshire4:27	Wiltshire4	immune cell quantification	doxorubicin	T cells, percent viability [%] Tcells_Dox 52427 dose [µM]: control 0.046 0.137 1.235 11.1 100	inbred w/CC7	35	m	10wks	N=4	2015

Wiltshire4:33	Wiltshire4	immune cell quantification	doxorubicin	monocytes, percent viability [%] monocytes_Dox 52433 dose [µM]: control 0.046 0.137 1.235 11.1 100	inbred w/CC7	35	m	10wks	N=4	2015

Wiltshire4:41	Wiltshire4	immune cell quantification	idarubicin	B cells, percent viability [%] Bcells_Ida 52441 dose [µM]: control 0.046 0.137 1.235 11.1 100	inbred w/CC7	35	m	10wks	N=4	2015

Wiltshire4:47	Wiltshire4	immune cell quantification	idarubicin	T cells, percent viability [%] Tcells_Ida 52447 dose [µM]: control 0.046 0.137 1.235 11.1 100	inbred w/CC7	35	m	10wks	N=4	2015

Wiltshire4:53	Wiltshire4	immune cell quantification	idarubicin	monocytes, percent viability [%] monocytes_Ida 52453 dose [µM]: control 0.046 0.137 1.235 11.1 100	inbred w/CC7	35	m	10wks	N=4	2015

Wiltshire4:61	Wiltshire4	immune cell quantification	selumetinib	B cells, percent viability [%] Bcells_Sel 52461 dose [µM]: control 0.046 0.137 1.235 11.1 100	inbred w/CC7	34	m	10wks	N=4	2015

Wiltshire4:67	Wiltshire4	immune cell quantification	selumetinib	T cells, percent viability [%] Tcells_Sel 52467 dose [µM]: control 0.046 0.137 1.235 11.1 100	inbred w/CC7	34	m	10wks	N=4	2015

Wiltshire4:73	Wiltshire4	immune cell quantification	selumetinib	monocytes, percent viability [%] monocytes_Sel 52473 dose [µM]: control 0.046 0.137 1.235 11.1 100	inbred w/CC7	34	m	10wks	N=4	2015

Wittenburg1:2	Wittenburg1	organ weights	high-fat diet	liver weight [g] liver_wt 12602	QTL population		both	18-20wks	N=130	2002

Wittenburg1:3	Wittenburg1	organ weights	high-fat diet	liver-to-bw ratio [ratio] liver_bw_ratio 12603	QTL population		both	18-20wks	N=130	2002

Wittenburg1:4	Wittenburg1	organ dimensions	high-fat diet	gallbladder, volume [µL] gallbladder_vol 12604	QTL population		both	18-20wks	N=130	2002

Wittenburg1:5	Wittenburg1	histopathology	high-fat diet	gallbladder, mucin (score 0-4), log transformed [score] gallbladder_mucin_log 12605	QTL population		both	18-20wks	N=130	2002

Wittenburg1:6	Wittenburg1	histopathology	high-fat diet	gallstones, presence (score 0=absent, 1=present) [score] gallstone_presence 12606	QTL population		both	18-20wks	N=130	2002

Wittenburg1:7	Wittenburg1	histopathology	high-fat diet	gallstones, number [n] gallstone_count 12607	QTL population		both	18-20wks	N=130	2002

Wittenburg1:8	Wittenburg1	histopathology	high-fat diet	weight of solid gallstones [mg] gallstone_wt 12608	QTL population		both	18-20wks	N=130	2002

Wittenburg1:9	Wittenburg1	histopathology	high-fat diet	gallstone severity (score 0=absent, 1=crystals, 2=stones) [score] gallstone_score 12609	QTL population		both	18-20wks	N=130	2002

Wittenburg1:10	Wittenburg1	histopathology	high-fat diet	gallstones volume gallstone_vol 12610	QTL population		both	18-20wks	N=130	2002

Wittenburg2:3	Wittenburg2	organ weights	high-fat diet	liver weight [g] liver_wt 13803	QTL population		both	14-16wks	N=152	2003

Wittenburg2:4	Wittenburg2	organ weights	high-fat diet	percentage of total body weight that is liver weight [%] liver_wt_pct 13804	QTL population		both	14-16wks	N=152	2003

Wittenburg2:5	Wittenburg2	organ dimensions	high-fat diet	gallbladder, volume [µL] gallbladder_vol 13805	QTL population		both	14-16wks	N=152	2003

Wittenburg2:6	Wittenburg2	histopathology	high-fat diet	gallbladder, mucin (score 0-5) [score] gallbladder_mucin 13806	QTL population		both	14-16wks	N=152	2003

Wittenburg2:7	Wittenburg2	histopathology	high-fat diet	gallstones, presence (score 0=absent, 1=present) [score] gallstone_presence 13807	QTL population		both	14-16wks	N=152	2003

Wittenburg2:8	Wittenburg2	histopathology	high-fat diet	gallstones, screening (score 0=absent, 1=present, 2=solid gallstones) [score] gallstone_screen 13808	QTL population		both	14-16wks	N=152	2003

Wittenburg2:9	Wittenburg2	histopathology	high-fat diet	number of solid gallstones [n] gallstone_count 13809	QTL population		both	14-16wks	N=152	2003

Wittenburg2:10	Wittenburg2	histopathology	high-fat diet	weight of solid gallstones [mg] gallstone_wt 13810	QTL population		both	14-16wks	N=152	2003

Wittenburg2:11	Wittenburg2	histopathology	high-fat diet	weight of solid gallstones, log transformed [log(mg)] gallstone_wt_log 13811	QTL population		both	14-16wks	N=152	2003

Wittenburg2:12	Wittenburg2	histopathology	high-fat diet	weight of solid gallstones ([mg] + 1), log10 transformed [log(mg)] gallstone_wt_log10 13812	QTL population		both	14-16wks	N=152	2003

Wittenburg2:13	Wittenburg2	histopathology	high-fat diet	weight of solid gallstones, square root [sqrt(mg)] gallstone_wt_sqr 13813	QTL population		both	14-16wks	N=152	2003

Wittenburg2:14	Wittenburg2	histopathology	high-fat diet	gallstones, presence of sandy stones (score 0=absent, 1=present) [score] gallstone_sandy 13814	QTL population		both	14-16wks	N=152	2003

Wittenburg2:15	Wittenburg2	histopathology	high-fat diet	gallbladder, cholesterol monohydrate crystals (score 0-5) [score] gallstone_crystals 13815	QTL population		both	14-16wks	N=152	2003

Wittenburg2:16	Wittenburg2	histopathology	high-fat diet	gallstone severity (score 0-3) [score] gallstone_score 13816	QTL population		both	14-16wks	N=152	2003

Wittenburg3:2	Wittenburg3	organ weights	high-fat diet	liver weight [g] liver_wt 18202	QTL population		both	14-16wks	N=162	2005

Wittenburg3:3	Wittenburg3	organ weights	high-fat diet	percentage of body weight that is liver [%] pct_liver_wt 18203	QTL population		both	14-16wks	N=162	2005

Wittenburg3:4	Wittenburg3	organ dimensions	high-fat diet	gallbladder volume, log transformed [log(µL)] gallbladder_vol_log 18204	QTL population		both	14-16wks	N=162	2005

Wittenburg3:5	Wittenburg3	histopathology	high-fat diet	gallstones, presence (score 0=absent, 1=present) [score] gallstone_presence 18205	QTL population		both	14-16wks	N=162	2005

Wittenburg3:6	Wittenburg3	histopathology	high-fat diet	sandy gallstones, presence (score 0=absent, 1=present) [score] gallstone_sandy 18206	QTL population		both	14-16wks	N=162	2005

Wittenburg3:7	Wittenburg3	histopathology	high-fat diet	solid gallstones, presence (score 0=absent, 1=present) [score] gallstone_solid 18207	QTL population		both	14-16wks	N=162	2005

Wittenburg3:8	Wittenburg3	histopathology	high-fat diet	number of gallstones [n] gallstone_count 18208	QTL population		both	14-16wks	N=162	2005

Wittenburg3:9	Wittenburg3	histopathology	high-fat diet	gallstone weight [mg] gallstone_wt 18209	QTL population		both	14-16wks	N=162	2005

Wittenburg3:10	Wittenburg3	histopathology	high-fat diet	gallbladder, cholesterol monohydrate crystals (score 0=absent, 1-5=severity) [score] gallstone_crystals 18210	QTL population		both	14-16wks	N=162	2005

Wittenburg3:11	Wittenburg3	histopathology	high-fat diet	gallbladder, mucin (score 0=absent, 1-5=severity) [score] gallbladder_mucin 18211	QTL population		both	14-16wks	N=162	2005

Wittenburg3:12	Wittenburg3	histopathology	high-fat diet	gallstone score (score 0=absent, 1=crystals only, 2=sandy or solid gallstones) [score] gallstone_score 18212	QTL population		both	14-16wks	N=162	2005

Wittenburg3:13	Wittenburg3	histopathology	high-fat diet	gallstone severity index (score 0-3, increasing severity) [score] gallstone_severity 18213	QTL population		both	14-16wks	N=162	2005

Wittenburg3:18	Wittenburg3	histopathology	high-fat diet	gallstone weight if gallstones present [mg] gallstone_wt_if_present 18218	QTL population		both	14-16wks	N=162	2005

Wittenburg3:19	Wittenburg3	histopathology	high-fat diet	gallstones presence score (0=absent, 1=present) gallstone_present_absent 18219	QTL population		both	14-16wks	N=162	2005

Wittenburg3:20	Wittenburg3	histopathology	high-fat diet	Revised subjective summary score (0-3) score_new 18220	QTL population		both	14-16wks	N=162	2005

Xenakis2:246	Xenakis2	metabolite quantification	arsenic	inorganic arsenic (iAs) in liver (ppb), 24 wks after iAs [n] iAs_liver 118400	DO population		m	34wks	N=73	2022

Xenakis2:247	Xenakis2	metabolite quantification	arsenic	monomethyl-arsenic acid (MMA) in liver (ppb), 24 wks after iAs [n] MMA_liver 118401	DO population		m	34wks	N=73	2022

Xenakis2:248	Xenakis2	metabolite quantification	arsenic	dimethyl-arsenic acid (DMA) in liver (ppb), 24 wks after iAs [n] DMA_liver 118402	DO population		m	34wks	N=73	2022

Xenakis2:249	Xenakis2	metabolite quantification	arsenic	percentage of of inorganic arsenic (iAs) in liver, 24 wks after iAs [%] iAs_liver_pct 118403	DO population		m	34wks	N=73	2022

Xenakis2:250	Xenakis2	metabolite quantification	arsenic	percentage of monomethyl-arsenic acid (MMA) in liver, 24 wks after iAs [%] MMA_liver_pct 118404	DO population		m	34wks	N=73	2022

Xenakis2:251	Xenakis2	metabolite quantification	arsenic	percentage of dimethyl-arsenic acid (DMA) in liver, 24 wks after iAs [%] DMA_liver_pct 118405	DO population		m	34wks	N=73	2022

Yi1:6	Yi1	organ weights	(none)	liver weight at week 12 [mg] liver12wk 20606	QTL population		both	12wks	N=210	2007

All boxes To see more rows use the paging control at top.

Filter Table Results